uuid,short_qid,question,choices,unsure,target,llm_response,predicted,grade,correct,sure
33b801bb-9b47-4a0a-9314-05325c82fde7,bix-1_q1,What is the adjusted p-val threshold for T-cell activation related processes found in the GO enrichment?,,empty,p-adj < 0.05 for T cell activation terms,<answer>0.05</answer>,0.05,1,True,True
33b801bb-9b47-4a0a-9314-05325c82fde7,bix-1_q2,How many GO terms related to immune processes must show p-adj < 0.05 to establish significant enrichment of immune pathways in the dataset?,,empty,At least 1 term,"<answer>There is no specific number of GO terms with p-adj < 0.05 required to establish significant enrichment; it depends on the study context and statistical power. However, generally one or more significant terms could suggest enrichment.</answer>","There is no specific number of GO terms with p-adj < 0.05 required to establish significant enrichment; it depends on the study context and statistical power. However, generally one or more significant terms could suggest enrichment.",1,True,True
33b801bb-9b47-4a0a-9314-05325c82fde7,bix-1_q3,What variable must be included in the DESeq2 design formula to properly analyze the effect of ASXL1 mutations in a mixed-gender cohort?,,empty,sex,<answer>condition + gender</answer>,condition + gender,1,True,True
33b801bb-9b47-4a0a-9314-05325c82fde7,bix-1_q4,What clinical feature or criterion should be used as an exclusion factor for patients recruited in the study,,empty,Presence of confounding medical conditions,<answer>Evidence of active infection or significant comorbidity that could interfere with study outcomes should be used as an exclusion factor for patients recruited in the study.</answer>,Evidence of active infection or significant comorbidity that could interfere with study outcomes should be used as an exclusion factor for patients recruited in the study.,1,True,True
33b801bb-9b47-4a0a-9314-05325c82fde7,bix-1_q6,What is the adjusted p-value for neutrophil activation in the gene ontology analysis?,,empty,1.90E-5,<answer> The adjusted p-value for neutrophil activation in the gene ontology analysis is not provided as I do not have access to specific datasets or results. </answer>,The adjusted p-value for neutrophil activation in the gene ontology analysis is not provided as I do not have access to specific datasets or results.,0,False,True
30b33e47-92d8-4372-a9f6-da32896493d0,bix-2_q1,What is the proportion of likely somatic variants (VAF < 0.3) in BLM carriers relative to the total number of CHIP variants identified in this group?,,empty,0.05,<answer>0.65</answer>,0.65,0,False,True
30b33e47-92d8-4372-a9f6-da32896493d0,bix-2_q2,What is the percentage of CHIP variants with VAF between 0.3 and 0.7 in the Control Children cohort?,,empty,65%,<answer>Data not provided</answer>,Data not provided,0,False,True
30b33e47-92d8-4372-a9f6-da32896493d0,bix-2_q3,What proportion of CHIP variants fall into the exonic regions of the genome?,,empty,38.2%,<answer>Approximately 80% of CHIP variants fall into the exonic regions of the genome.</answer>,Approximately 80% of CHIP variants fall into the exonic regions of the genome.,0,False,True
30b33e47-92d8-4372-a9f6-da32896493d0,bix-2_q4,"What is the average number of CHIP variants per sample that pass all quality filters (DP>10, GQ>20, PASS) in the exonic regions?",,empty,53,<answer>3.5</answer>,3.5,0,False,True
94bcdbc9-c729-4661-9bc1-0057bbea39c4,bix-3_q1,"What's the number of genes that are differentially regulated, when comparing final vs baseline blood?",,empty,<1000,"<answer>Unfortunately, I cannot provide a specific number as the information regarding differentially regulated genes when comparing final versus baseline blood is not available in the data I have been trained on. Typically, this number would be determined through specific experimental studies and analyses.</answer>","Unfortunately, I cannot provide a specific number as the information regarding differentially regulated genes when comparing final versus baseline blood is not available in the data I have been trained on. Typically, this number would be determined through specific experimental studies and analyses.",0,False,True
94bcdbc9-c729-4661-9bc1-0057bbea39c4,bix-3_q2,What is the 95% confidence interval for the proportion of differentially expressed genes in the final vs baseline blood comparison?,,empty,"(0.0312, 0.0356)","<answer>To calculate the 95% confidence interval for the proportion of differentially expressed genes, you would typically need the sample proportion (p̂) and the sample size (n). The formula for the confidence interval is:

CI = p̂ ± Z * sqrt((p̂ * (1 - p̂)) / n)

Where Z is the Z-score corresponding to the confidence level (1.96 for 95%).

Since the specific data is not provided in the question, I cannot compute the exact confidence interval. Please provide the number of differentially expressed genes and the total number of genes for the computation.</answer>","To calculate the 95% confidence interval for the proportion of differentially expressed genes, you would typically need the sample proportion (p̂) and the sample size (n). The formula for the confidence interval is:

CI = p̂ ± Z * sqrt((p̂ * (1 - p̂)) / n)

Where Z is the Z-score corresponding to the confidence level (1.96 for 95%).

Since the specific data is not provided in the question, I cannot compute the exact confidence interval. Please provide the number of differentially expressed genes and the total number of genes for the computation.",0,False,True
94bcdbc9-c729-4661-9bc1-0057bbea39c4,bix-3_q3,How many genes show differential expression uniquely in the dentate gyrus vs baseline blood comparison after excluding genes shared with other comparisons?,,empty,766,<answer> The answer to the question is not provided in the prompt. </answer>,The answer to the question is not provided in the prompt.,0,False,True
94bcdbc9-c729-4661-9bc1-0057bbea39c4,bix-3_q4,"How many genes show consistent differential expression across all three tissue comparisons (final vs baseline blood, dentate gyrus vs baseline blood, and dentate gyrus vs final blood)?",,empty,429,<answer> The task does not provide sufficient data to determine the number of genes that show consistent differential expression across the specified tissue comparisons. </answer>,The task does not provide sufficient data to determine the number of genes that show consistent differential expression across the specified tissue comparisons.,0,False,True
94bcdbc9-c729-4661-9bc1-0057bbea39c4,bix-3_q5,"In a differential expression analysis comparing treatment effects in blood samples, what proportion of genes would need to show significant changes (padj < 0.05, |log2FC| > 1) to reject the hypothesis of negligible treatment effects?",,empty,More than 5% of total genes,"<answer>There is no fixed proportion of genes that must show significant changes to reject the hypothesis of negligible treatment effects; it depends on the specific context, experimental design, and variability in the data. However, typically, a researcher may look for a substantial subset of genes, potentially greater than 10-15%, showing significant changes to consider the treatment effects non-negligible.</answer>","There is no fixed proportion of genes that must show significant changes to reject the hypothesis of negligible treatment effects; it depends on the specific context, experimental design, and variability in the data. However, typically, a researcher may look for a substantial subset of genes, potentially greater than 10-15%, showing significant changes to consider the treatment effects non-negligible.",1,True,True
ec9eb551-feee-48f6-8494-fd85e1521881,bix-4_q1,"What percentage of fungal genes in the dataset exhibit DVMC values below 0.3, indicating strong clock-like evolution?",,empty,57%,"<answer>Sorry, I don't have access to specific datasets or their analyses, including percentage calculations of fungal genes exhibiting DVMC values below 0.3. Therefore, I cannot provide a precise answer to this question.</answer>","Sorry, I don't have access to specific datasets or their analyses, including percentage calculations of fungal genes exhibiting DVMC values below 0.3. Therefore, I cannot provide a precise answer to this question.",0,False,True
ec9eb551-feee-48f6-8494-fd85e1521881,bix-4_q2,What is the mean DVMC value for genes within the animal dataset?,,empty,0.57,"<answer>There is no specific ""animal dataset"" or ""DVMC value for genes"" provided to determine a mean value. Please provide the dataset or context for accurate information.</answer>","There is no specific ""animal dataset"" or ""DVMC value for genes"" provided to determine a mean value. Please provide the dataset or context for accurate information.",0,False,True
ec9eb551-feee-48f6-8494-fd85e1521881,bix-4_q3,What is the Mann Whitney U value between fungi and animal DVMC values?,,empty,19808,"<answer>To determine the Mann Whitney U value between fungi and animal DVMC values, you would need the specific DVMC data points for each group. Unfortunately, I cannot compute this value without the actual data. If you have the data, you can perform the Mann Whitney U test using statistical software to obtain the U value.</answer>","To determine the Mann Whitney U value between fungi and animal DVMC values, you would need the specific DVMC data points for each group. Unfortunately, I cannot compute this value without the actual data. If you have the data, you can perform the Mann Whitney U test using statistical software to obtain the U value.",0,False,True
ec9eb551-feee-48f6-8494-fd85e1521881,bix-4_q4,What is the standard deviation of DVMC values among genes in the animal dataset?,,empty,0.30,<answer> The standard deviation of DVMC values among genes in the animal dataset is not provided in the prompt. </answer>,The standard deviation of DVMC values among genes in the animal dataset is not provided in the prompt.,0,False,True
ec9eb551-feee-48f6-8494-fd85e1521881,bix-4_q5,What is the median DVMC value for fungal genes?,,empty,0.27,<answer>Data on the median DVMC (Disease-Vulnerability of Microorganism Community) value for fungal genes is not publicly specified. Further research or access to specific datasets may be needed to determine this value.</answer>,Data on the median DVMC (Disease-Vulnerability of Microorganism Community) value for fungal genes is not publicly specified. Further research or access to specific datasets may be needed to determine this value.,0,False,True
ec9eb551-feee-48f6-8494-fd85e1521881,bix-4_q6,What is the highest DVMC value observed among animal genes?,,empty,1.58,<answer>10.6</answer>,10.6,0,False,True
ec9eb551-feee-48f6-8494-fd85e1521881,bix-4_q7,What is the DVMC value for the orthologous gene 324863at2759 in fungi?,,empty,0.45,"<answer>As of my last update, specific DVMC values for gene 324863at2759 in fungi are not readily available in public databases or resources. DVMC values would typically be retrieved from specific studies or datasets that focus on the evolutionary conservation or divergence of particular genes across species. Please consult specialized databases or recent research articles for the most accurate data.</answer>","As of my last update, specific DVMC values for gene 324863at2759 in fungi are not readily available in public databases or resources. DVMC values would typically be retrieved from specific studies or datasets that focus on the evolutionary conservation or divergence of particular genes across species. Please consult specialized databases or recent research articles for the most accurate data.",0,False,True
2a8a40d4-05b0-4eec-8bd2-825f61fc9f5d,bix-5_q1,Which is statistically the most enriched GO process in BOS-patient fibroblasts?,,empty,Potassium ion transmembrane transport,"<answer>Without specific dataset analysis provided in this context, it's not possible to definitively state the most enriched GO process in BOS-patient fibroblasts. However, for general guidance related to BOS (Bohring-Opitz Syndrome), some common enriched processes might include developmental processes or cell growth. For exact results, refer to a specific bioinformatic study or dataset analysis.</answer>","Without specific dataset analysis provided in this context, it's not possible to definitively state the most enriched GO process in BOS-patient fibroblasts. However, for general guidance related to BOS (Bohring-Opitz Syndrome), some common enriched processes might include developmental processes or cell growth. For exact results, refer to a specific bioinformatic study or dataset analysis.",0,False,True
2a8a40d4-05b0-4eec-8bd2-825f61fc9f5d,bix-5_q2,What is the lowest adjusted p-value threshold of membrane potential regulation processes resulting from the enrichment?,,empty,0.01,"<answer>Without specific data or results from enrichment analysis related to membrane potential regulation processes, I am unable to provide the lowest adjusted p-value threshold. Please refer to the relevant analysis output for this information.</answer>","Without specific data or results from enrichment analysis related to membrane potential regulation processes, I am unable to provide the lowest adjusted p-value threshold. Please refer to the relevant analysis output for this information.",0,False,True
2a8a40d4-05b0-4eec-8bd2-825f61fc9f5d,bix-5_q3,How many independent ion transport-related processes are significantly enriched in the GO analysis results?,,empty,3,<answer> The information needed to answer this question is not provided in the prompt. </answer>,The information needed to answer this question is not provided in the prompt.,0,False,True
2a8a40d4-05b0-4eec-8bd2-825f61fc9f5d,bix-5_q4,What impact would reducing the GO term similarity cutoff from 0.7 to 0.5 in the simplification step have on the number of significant membrane-related processes?,,empty,Increase the number of significant terms,"<answer>Reducing the GO term similarity cutoff from 0.7 to 0.5 would likely increase the number of significant membrane-related processes by allowing more diverse terms that are less similar to each other to be considered significant. This wider threshold would include a broader range of related terms, capturing more relevant biological processes.</answer>","Reducing the GO term similarity cutoff from 0.7 to 0.5 would likely increase the number of significant membrane-related processes by allowing more diverse terms that are less similar to each other to be considered significant. This wider threshold would include a broader range of related terms, capturing more relevant biological processes.",1,True,True
2a8a40d4-05b0-4eec-8bd2-825f61fc9f5d,bix-5_q5,Which is the most enriched process in the ASXL1-mutated fibroblasts?,,empty,Potassium ion transmembrane transport,<answer>Histone modification</answer>,Histone modification,0,False,True
2a8a40d4-05b0-4eec-8bd2-825f61fc9f5d,bix-5_q6,"For a given set of differentially expressed genes in fibroblasts, what is the adjusted p-value threshold used to determine significant GO term enrichment?",,empty,0.05,<answer>0.05</answer>,0.05,1,True,True
2a8a40d4-05b0-4eec-8bd2-825f61fc9f5d,bix-5_q7,What similarity cutoff value is used to reduce redundancy in the GO term analysis?,,empty,0.7,<answer>0.4</answer>,0.4,0,False,True
f4dcda89-678d-403d-b155-1483d0071765,bix-6_q1,"Based on the pathway enrichment analysis of T cell evasion genes, at what timepoint does immune pathway regulation show the strongest evidence of selective pressure?",,empty,During chronic round 2 (day 6),<answer>There is no specific timepoint mentioned in the provided context regarding the strongest evidence of selective pressure on immune pathway regulation. More information or context from the pathway enrichment analysis study would be needed to provide a precise timepoint.</answer>,There is no specific timepoint mentioned in the provided context regarding the strongest evidence of selective pressure on immune pathway regulation. More information or context from the pathway enrichment analysis study would be needed to provide a precise timepoint.,0,False,True
f4dcda89-678d-403d-b155-1483d0071765,bix-6_q2,What is the adjusted p-value threshold required to identify significant pathway enrichment in the acute T cell exposure analysis?,,empty,0.05,<answer>The adjusted p-value threshold required to identify significant pathway enrichment is typically set at 0.05 or below.</answer>,The adjusted p-value threshold required to identify significant pathway enrichment is typically set at 0.05 or below.,1,True,True
f4dcda89-678d-403d-b155-1483d0071765,bix-6_q3,How many pathways maintain significant enrichment (adjusted p-value < 0.05) across all three rounds of chronic T cell exposure?,,empty,0 pathways,"```xml
<answer> The answer to this question is not directly available in the input provided. Additional context or data is needed to determine the number of pathways maintaining significant enrichment across the three rounds of chronic T cell exposure. </answer>
```",The answer to this question is not directly available in the input provided. Additional context or data is needed to determine the number of pathways maintaining significant enrichment across the three rounds of chronic T cell exposure.,0,False,True
f4dcda89-678d-403d-b155-1483d0071765,bix-6_q4,What is the Spearman correlation coefficient between replicates for genes identified in chronic round 1 of T cell exposure?,,empty,0.021,"<answer>There is no specific Spearman correlation coefficient that can be provided without additional experimental data for ""genes identified in chronic round 1 of T cell exposure."" The Spearman correlation coefficient needs specific data inputs to be calculated.</answer>","There is no specific Spearman correlation coefficient that can be provided without additional experimental data for ""genes identified in chronic round 1 of T cell exposure."" The Spearman correlation coefficient needs specific data inputs to be calculated.",0,False,True
f4dcda89-678d-403d-b155-1483d0071765,bix-6_q5,What proportion of screening conditions showed significant enrichment of immune-relevant pathways in genes associated with T cell evasion?,,empty,1/4 conditions,"<answer>Without specific data or context from a particular study or dataset, I cannot provide an exact proportion. Additional information from a relevant study would be necessary to answer this question accurately.</answer>","Without specific data or context from a particular study or dataset, I cannot provide an exact proportion. Additional information from a relevant study would be necessary to answer this question accurately.",0,False,True
f4dcda89-678d-403d-b155-1483d0071765,bix-6_q6,What correlation value is observed between replicates in the acute T cell screen?,,empty,0.021,<answer>0.93</answer>,0.93,0,False,True
f4dcda89-678d-403d-b155-1483d0071765,bix-6_q7,"In chronic screen round 2, what is the odds ratio for the most significantly enriched pathway?",,empty,9.41,"I'm sorry, I do not have specific data or results from ""chronic screen round 2"" to provide an odds ratio for the most significantly enriched pathway. If you could provide more context or details, I might be able to help further.",,0,False,True
a02b761a-02b6-46b5-9d5e-2964d5a74960,bix-7_q1,What is the relationship between BLM mutation status and CHIP variant frequency in the analyzed exome sequencing data?,,empty,CHIP variant frequencies show no statistically significant differences between groups,"<answer>The relationship between BLM mutation status and CHIP (clonal hematopoiesis of indeterminate potential) variant frequency in the analyzed exome sequencing data is not explicitly defined in current literature. However, BLM mutations, which are associated with genomic instability, may potentially influence the frequency of CHIP variants, as CHIP involves the acquisition of somatic mutations in hematopoietic cells. Further studies would be necessary to elucidate any direct correlation between BLM mutations and CHIP variant frequency.</answer>","The relationship between BLM mutation status and CHIP (clonal hematopoiesis of indeterminate potential) variant frequency in the analyzed exome sequencing data is not explicitly defined in current literature. However, BLM mutations, which are associated with genomic instability, may potentially influence the frequency of CHIP variants, as CHIP involves the acquisition of somatic mutations in hematopoietic cells. Further studies would be necessary to elucidate any direct correlation between BLM mutations and CHIP variant frequency.",0,False,True
a02b761a-02b6-46b5-9d5e-2964d5a74960,bix-7_q2,"What is the average number of CHIP variants per sample after filtering out intronic, intergenic, and UTR variants?",,empty,40-60 variants,"<answer>Data on the average number of CHIP (Clonal Hematopoiesis of Indeterminate Potential) variants per sample, specifically after filtering out intronic, intergenic, and UTR variants, is not consistent across studies because it depends on the sample type and method used for variant filtering. Typically, only a few variants are identified per sample. A common observation might be around 1 to 3 variants per sample, but this can vary significantly based on the study specifics.</answer>","Data on the average number of CHIP (Clonal Hematopoiesis of Indeterminate Potential) variants per sample, specifically after filtering out intronic, intergenic, and UTR variants, is not consistent across studies because it depends on the sample type and method used for variant filtering. Typically, only a few variants are identified per sample. A common observation might be around 1 to 3 variants per sample, but this can vary significantly based on the study specifics.",0,False,True
a02b761a-02b6-46b5-9d5e-2964d5a74960,bix-7_q3,How many CHIP variants remain after removing reference calls from the dataset?,,empty,10k-20k,"<answer> Without specific data, it's impossible to determine the exact number of CHIP variants. </answer>","Without specific data, it's impossible to determine the exact number of CHIP variants.",0,False,True
a02b761a-02b6-46b5-9d5e-2964d5a74960,bix-7_q4,How many distinct sample groups are represented in the final CHIP variant analysis after proper classification of control samples?,,empty,4 groups,<answer>3</answer>,3,0,False,True
48a6b469-9c9d-4bef-b5b4-f29b7d6fa046,bix-8_q1,What proportion of hypermethylated genes (m6A Hyper) in the dataset show increased expression (Up) in bladder cancer?,,empty,0.156 (15.6%),"<answer>I'm sorry, I cannot provide an answer without access to the specific dataset or detailed results from the study in question.</answer>","I'm sorry, I cannot provide an answer without access to the specific dataset or detailed results from the study in question.",0,False,True
48a6b469-9c9d-4bef-b5b4-f29b7d6fa046,bix-8_q2,What is the chi-square statistic for the independence test between m6A methylation status and differential expression status in the dataset?,,empty,901.45,"<answer>To determine the chi-square statistic for the independence test between m6A methylation status and differential expression status, you would typically need a contingency table with observed frequencies of different categories. Without specific data provided, it's not possible to calculate the actual chi-square statistic directly in this context.</answer>","To determine the chi-square statistic for the independence test between m6A methylation status and differential expression status, you would typically need a contingency table with observed frequencies of different categories. Without specific data provided, it's not possible to calculate the actual chi-square statistic directly in this context.",0,False,True
48a6b469-9c9d-4bef-b5b4-f29b7d6fa046,bix-8_q3,What is the ratio of hypermethylated to hypomethylated genes among all differentially methylated genes in the dataset?,,empty,1.33,"```xml
<answer> The ratio is not specified or provided in the prompt. </answer>
```",The ratio is not specified or provided in the prompt.,0,False,True
48a6b469-9c9d-4bef-b5b4-f29b7d6fa046,bix-8_q4,"For genes with significant differential methylation, what is the odds ratio of finding upregulated versus downregulated genes in hypermethylated compared to hypomethylated genes?",,empty,74.3,"<answer>The odds ratio for upregulated versus downregulated genes in hypermethylated compared to hypomethylated genes typically suggests that hypermethylation is associated with gene silencing, resulting in more downregulated genes, while hypomethylation is associated with gene activation, leading to more upregulated genes. However, the exact odds ratio can vary depending on specific study data and context.</answer>","The odds ratio for upregulated versus downregulated genes in hypermethylated compared to hypomethylated genes typically suggests that hypermethylation is associated with gene silencing, resulting in more downregulated genes, while hypomethylation is associated with gene activation, leading to more upregulated genes. However, the exact odds ratio can vary depending on specific study data and context.",0,False,True
48a6b469-9c9d-4bef-b5b4-f29b7d6fa046,bix-8_q5,What is the p-value of the statistical test examining the independence between m6A methylation status and differential expression in bladder cancer?,,empty,p < 2.2e-16,<answer>I don't have access to specific data or study results. Please refer to the original research paper or dataset for the p-value information.</answer>,I don't have access to specific data or study results. Please refer to the original research paper or dataset for the p-value information.,0,False,True
48a6b469-9c9d-4bef-b5b4-f29b7d6fa046,bix-8_q6,How many genes show significant hypermethylation in bladder cancer samples?,,empty,680,"<answer> Approximately 150-700 genes show significant hypermethylation in bladder cancer samples, depending on the specific study and criteria used for significance. </answer>","Approximately 150-700 genes show significant hypermethylation in bladder cancer samples, depending on the specific study and criteria used for significance.",1,True,True
873bada5-b1f3-423a-87dc-9ddd486c4843,bix-9_q1,"By performing a two-way ANOVA analysis on the gene expression data, what is the statistical strength (F-statistic and p-value) of the interaction between tissue type and treatment response?",,empty,F = 10.09 (p < 0.0001),"```xml
<answer>To determine the statistical strength of the interaction between tissue type and treatment response using a two-way ANOVA, specific data input and analysis are required. Assuming the analysis has been conducted, the interaction's F-statistic and p-value would be reported specific to the dataset analyzed.</answer>
```","To determine the statistical strength of the interaction between tissue type and treatment response using a two-way ANOVA, specific data input and analysis are required. Assuming the analysis has been conducted, the interaction's F-statistic and p-value would be reported specific to the dataset analyzed.",0,False,True
873bada5-b1f3-423a-87dc-9ddd486c4843,bix-9_q2,How many differentially expressed genes are shared between brain tissue and blood samples in bad responders versus controls?,,empty,2 genes,<answer>There is no specific number provided in the available data. Please refer to a specific study or dataset for exact information.</answer>,There is no specific number provided in the available data. Please refer to a specific study or dataset for exact information.,0,False,True
873bada5-b1f3-423a-87dc-9ddd486c4843,bix-9_q3,"In the dentate gyrus, what is the pattern of overlap in differentially expressed genes between good responders, bad responders, and controls?",,empty,No overlap between any groups,"<answer>The dentate gyrus displays distinct patterns of gene expression in good responders, bad responders, and controls, with certain genes being uniquely differentially expressed in each group and some overlap between groups. Good responders and bad responders may share some differentially expressed genes in comparison to controls, but they also exhibit specific patterns unique to their response status.</answer>","The dentate gyrus displays distinct patterns of gene expression in good responders, bad responders, and controls, with certain genes being uniquely differentially expressed in each group and some overlap between groups. Good responders and bad responders may share some differentially expressed genes in comparison to controls, but they also exhibit specific patterns unique to their response status.",0,False,True
873bada5-b1f3-423a-87dc-9ddd486c4843,bix-9_q4,"What is the statistical significance level (p-value) of the Category effect in the one-way ANOVA testing for tissue-response interactions? (""Category"" here means the concatenation of ""Tissue"" and ""Response"")",,empty,p = 9.92e-35,"```xml
<answer> Not enough context provided to determine the p-value. </answer>
```",Not enough context provided to determine the p-value.,0,False,True
873bada5-b1f3-423a-87dc-9ddd486c4843,bix-9_q5,In which tissue type do bad responders show the highest number of significant (p < 0.05) differentially expressed genes compared to controls?,,empty,Dentate gyrus (brain),<answer>It is not possible to determine the tissue type with the highest number of significant differentially expressed genes in bad responders compared to controls without specific data or research context. Please provide more information or refer to a specific study.</answer>,It is not possible to determine the tissue type with the highest number of significant differentially expressed genes in bad responders compared to controls without specific data or research context. Please provide more information or refer to a specific study.,0,False,True
fbe0e950-76f2-4eb7-a216-a2d377970922,bix-10_q1,What is the effect of BCG vaccination on COVID-19 severity when controlling for patient interaction frequency in healthcare workers?,,empty,Increases severity odds by 52.4%,"<answer>Current evidence on the effect of BCG vaccination on COVID-19 severity is inconclusive. Some studies suggest possible benefits, such as reduced severity, particularly among healthcare workers, but results are inconsistent and may be confounded by factors like age, comorbidities, and exposure frequency. Continued research is needed to determine any definitive protective effects when controlling for patient interaction frequency in healthcare workers.</answer>","Current evidence on the effect of BCG vaccination on COVID-19 severity is inconclusive. Some studies suggest possible benefits, such as reduced severity, particularly among healthcare workers, but results are inconsistent and may be confounded by factors like age, comorbidities, and exposure frequency. Continued research is needed to determine any definitive protective effects when controlling for patient interaction frequency in healthcare workers.",0,False,True
fbe0e950-76f2-4eb7-a216-a2d377970922,bix-10_q2,What is the relationship between healthcare workers' expected patient interaction and COVID-19 severity?,,empty,Expected interaction reduces severity odds by 24.5%,"<answer>The relationship between healthcare workers' expected patient interaction and COVID-19 severity is that those with higher patient interaction often face increased exposure to the virus, potentially leading to more severe health risks and stricter preventive measures to mitigate infection rates.</answer>","The relationship between healthcare workers' expected patient interaction and COVID-19 severity is that those with higher patient interaction often face increased exposure to the virus, potentially leading to more severe health risks and stricter preventive measures to mitigate infection rates.",0,False,True
fbe0e950-76f2-4eb7-a216-a2d377970922,bix-10_q3,How does the distribution of COVID-19 severity differ among healthcare workers seeing different numbers of patients?,,empty,Significant difference only in the 1-50 patients group,"<answer>The distribution of COVID-19 severity among healthcare workers is influenced by their exposure levels. Healthcare workers seeing a higher number of patients, especially those in direct contact with COVID-19 patients, tend to have higher exposure, potentially leading to more severe cases. Conversely, healthcare workers seeing fewer patients may experience mild symptoms due to reduced exposure. Other factors like personal protective equipment availability and pre-existing health conditions also play significant roles.</answer>","The distribution of COVID-19 severity among healthcare workers is influenced by their exposure levels. Healthcare workers seeing a higher number of patients, especially those in direct contact with COVID-19 patients, tend to have higher exposure, potentially leading to more severe cases. Conversely, healthcare workers seeing fewer patients may experience mild symptoms due to reduced exposure. Other factors like personal protective equipment availability and pre-existing health conditions also play significant roles.",0,False,True
fbe0e950-76f2-4eb7-a216-a2d377970922,bix-10_q4,"Using a chi-square test, what is the p-value for the association between BCG vaccination and COVID-19 severity among healthcare workers who expect to interact with patients?",,empty,0.025,"<answer>To determine the p-value using a chi-square test, you need specific data such as the observed and expected frequencies of COVID-19 severity among vaccinated and non-vaccinated healthcare workers. Without this data, it's not possible to calculate the p-value. Please provide the necessary data to proceed.</answer>","To determine the p-value using a chi-square test, you need specific data such as the observed and expected frequencies of COVID-19 severity among vaccinated and non-vaccinated healthcare workers. Without this data, it's not possible to calculate the p-value. Please provide the necessary data to proceed.",0,False,True
fbe0e950-76f2-4eb7-a216-a2d377970922,bix-10_q5,What is the effect of BCG re-vaccination on COVID-19 severity odds among healthcare workers who interact with patients?,,empty,Increases severity odds by 34.4%,"<answer>There is limited and mixed evidence on the effect of BCG re-vaccination on COVID-19 severity odds among healthcare workers. Some studies suggest that BCG vaccination may provide non-specific immune benefits that could reduce the severity of COVID-19, but these findings are not consistent across all research. More robust, large-scale trials are needed to draw definitive conclusions.</answer>","There is limited and mixed evidence on the effect of BCG re-vaccination on COVID-19 severity odds among healthcare workers. Some studies suggest that BCG vaccination may provide non-specific immune benefits that could reduce the severity of COVID-19, but these findings are not consistent across all research. More robust, large-scale trials are needed to draw definitive conclusions.",0,False,True
fbe0e950-76f2-4eb7-a216-a2d377970922,bix-10_q6,"For healthcare workers seeing 1-50 patients, what is the statistical significance (p-value) of the association between vaccination status and disease severity?",,empty,p = 0.024,"<answer>Statistical significance, indicated by a p-value, cannot be determined without specific data or context, such as the dataset and the statistical test used. More information is needed to provide a p-value.</answer>","Statistical significance, indicated by a p-value, cannot be determined without specific data or context, such as the dataset and the statistical test used. More information is needed to provide a p-value.",0,False,True
fbe0e950-76f2-4eb7-a216-a2d377970922,bix-10_q7,How do the odds of higher COVID-19 severity compare between healthcare workers who expect to interact with patients versus those who do not?,,empty,24.5% lower odds,"<answer>The odds of higher COVID-19 severity are generally higher for healthcare workers who expect to interact with patients compared to those who do not, due to increased exposure risk.</answer>","The odds of higher COVID-19 severity are generally higher for healthcare workers who expect to interact with patients compared to those who do not, due to increased exposure risk.",0,False,True
cd811ead-7887-4369-b175-05aff4223765,bix-11_q1,What is the magnitude of difference in median treeness values between fungi and animals?,,empty,0.05,<answer>20</answer>,20,0,False,True
cd811ead-7887-4369-b175-05aff4223765,bix-11_q2,What percentage of fungal genes show treeness values above 0.06?,,empty,35%,<answer>52.7%</answer>,52.7%,0,False,True
cd811ead-7887-4369-b175-05aff4223765,bix-11_q3,What is the treeness value of the most divergent ortholog (highest treeness) in the animal dataset?,,empty,0.1126,"```xml
<answer> 0.94118 </answer>
```",0.94118,0,False,True
cd811ead-7887-4369-b175-05aff4223765,bix-11_q4,What is the Mann-Whitney U statistic for the comparison of treeness values between fungi and animals?,,empty,3556.0,"<answer>To compute the Mann-Whitney U statistic for treeness values between fungi and animals, specific numerical data from each group is required. Please provide the relevant numeric datasets for those groups to calculate the U statistic.</answer>","To compute the Mann-Whitney U statistic for treeness values between fungi and animals, specific numerical data from each group is required. Please provide the relevant numeric datasets for those groups to calculate the U statistic.",0,False,True
cd811ead-7887-4369-b175-05aff4223765,bix-11_q5,What is the p-value for the Mann-Whitney U test comparing treeness values between fungi and animals?,,empty,0.0012,"<answer>To determine the p-value for the Mann-Whitney U test, specific data on the treeness values for fungi and animals is required, which is not provided here. Typically, this involves statistical software or calculations that need those data inputs. Hence, the p-value cannot be specified without further information.</answer>","To determine the p-value for the Mann-Whitney U test, specific data on the treeness values for fungi and animals is required, which is not provided here. Typically, this involves statistical software or calculations that need those data inputs. Hence, the p-value cannot be specified without further information.",0,False,True
cd811ead-7887-4369-b175-05aff4223765,bix-11_q6,What is the median treeness value for fungal orthologs?,,empty,0.0489,<answer>0.81</answer>,0.81,0,False,True
d38392ec-84b8-485d-ab02-b8788e6f1f43,bix-12_q1,What does the distribution of parsimony informative sites in fungal proteins suggest about their evolutionary rate compared to animal proteins?,,empty,Fungal proteins evolve more rapidly than animal proteins,"<answer>The distribution of parsimony informative sites in fungal proteins suggests that they generally have a slower evolutionary rate compared to animal proteins, indicating greater conservation over time.</answer>","The distribution of parsimony informative sites in fungal proteins suggests that they generally have a slower evolutionary rate compared to animal proteins, indicating greater conservation over time.",0,False,True
d38392ec-84b8-485d-ab02-b8788e6f1f43,bix-12_q2,What is the median percentage of parsimony informative (variable) sites across all single-copy orthologous genes in fungi?,,empty,3.5%,<answer>20%</answer>,20%,0,False,True
d38392ec-84b8-485d-ab02-b8788e6f1f43,bix-12_q3,What is the ratio of percent parsimony informative (variable) sites between the most conserved fungal gene and the most conserved animal gene in the dataset?,,empty,3.0,"```xml
<answer> The ratio is not explicitly available without specific datasets. You may need to analyze a dataset of conserved fungal and animal genes to determine this ratio. </answer>
```",The ratio is not explicitly available without specific datasets. You may need to analyze a dataset of conserved fungal and animal genes to determine this ratio.,0,False,True
d38392ec-84b8-485d-ab02-b8788e6f1f43,bix-12_q4,What is the Mann-Whitney U test value when comparing the percentage of parsimony informative (variable) sites between animals and fungi?,,empty,6948.0,"```xml
<answer>N/A</answer>
```",,0,False,True
d38392ec-84b8-485d-ab02-b8788e6f1f43,bix-12_q5,What is the maximum number of parsimony informative sites found in any single animal ortholog alignment?,,empty,29,"<answer>It is not possible to determine a specific maximum number of parsimony informative sites in a single animal ortholog alignment as this can vary greatly depending on the species, the gene in question, and the length of the alignment. Specific data or studies would need to be referenced for a precise answer.</answer>","It is not possible to determine a specific maximum number of parsimony informative sites in a single animal ortholog alignment as this can vary greatly depending on the species, the gene in question, and the length of the alignment. Specific data or studies would need to be referenced for a precise answer.",0,False,True
d38392ec-84b8-485d-ab02-b8788e6f1f43,bix-12_q6,What is the Mann-Whitney U test statistic when comparing the number of parsimony informative sites between animal and fungal alignments?,,empty,6748.0,"<answer>To determine the Mann-Whitney U test statistic, one would need specific data from the alignments being compared. Without that data, the test statistic cannot be calculated here.</answer>","To determine the Mann-Whitney U test statistic, one would need specific data from the alignments being compared. Without that data, the test statistic cannot be calculated here.",0,False,True
1d54e4a7-8b0f-4224-bd31-efcfded0d46c,bix-13_q1,"What percentage of genes differentially expressed in strain JBX97 are exclusively also differentially expressed in strain JBX99, relative to strain JBX1 (logfold cutoff either > 1.5 or < -1.5)?",,empty,10.6%,"```xml
<answer>30%</answer>
```",30%,0,False,True
1d54e4a7-8b0f-4224-bd31-efcfded0d46c,bix-13_q2,"How many genes are uniquely differentially expressed in strain 98 but not in either of strains JBX97 or JBX99, relative to strain JBX1 (logfold cutoff either > 1.5 or < -1.5)?",,empty,166,<answer>52</answer>,52,0,False,True
1d54e4a7-8b0f-4224-bd31-efcfded0d46c,bix-13_q3,How many genes have a dispersion value below 1e-05 when using DEseq for analysis?,,empty,7,<answer> The number of genes with a dispersion value below 1e-05 when using DEseq for analysis is not a fixed value and depends on the specific dataset being analyzed. </answer>,The number of genes with a dispersion value below 1e-05 when using DEseq for analysis is not a fixed value and depends on the specific dataset being analyzed.,0,False,True
1d54e4a7-8b0f-4224-bd31-efcfded0d46c,bix-13_q4,Which strain and media condition do replicates not fully cluster together based on pairwise correlation after regularized log transformation of the differential expression analysis results?,,empty,Strain 99 in Succinate,"<answer>Without specific data or context provided, it's not possible to determine which strain and media condition do not fully cluster together based on pairwise correlation after regularized log transformation. This analysis requires specific results from a differential expression study. Please provide the necessary data or context for a precise answer.</answer>","Without specific data or context provided, it's not possible to determine which strain and media condition do not fully cluster together based on pairwise correlation after regularized log transformation. This analysis requires specific results from a differential expression study. Please provide the necessary data or context for a precise answer.",0,False,True
1d54e4a7-8b0f-4224-bd31-efcfded0d46c,bix-13_q5,"Of all differentially expressed genes (FDR<0.05, logfold cutoff either > 1.5 or < -1.5), what is the total percentage of genes either exclusively affected in ∆rhlI or ∆lasI?",,empty,8.1%,"<answer> The percentage of genes exclusively affected in ∆rhlI or ∆lasI cannot be determined without specific data from an experimental analysis that includes a list of differentially expressed genes, their FDR, and logfold cutoff values. </answer>","The percentage of genes exclusively affected in ∆rhlI or ∆lasI cannot be determined without specific data from an experimental analysis that includes a list of differentially expressed genes, their FDR, and logfold cutoff values.",0,False,True
1d54e4a7-8b0f-4224-bd31-efcfded0d46c,bix-13_q6,"How many genes are differentially expressed (FDR < 0.05, logfold cutoff either > 1.5 or < -1.5) in at least one of the ΔlasI or ΔrhlI single mutants but are not differentially expressed in the ΔlasIΔrhlI double mutant?
",,empty,397,"```xml
<answer> This question requires specific experimental data from a study, which is not available in this context. Please refer to the relevant scientific literature or data set for the answer. </answer>
```","This question requires specific experimental data from a study, which is not available in this context. Please refer to the relevant scientific literature or data set for the answer.",0,False,True
7718a922-ce2c-4e59-900b-84fe06050ce6,bix-14_q1,What mechanism explains the similar distribution of CHIP variant effects between Bloom syndrome patients and controls?,,empty,BLM helicase affects variant repair frequency but not variant type selection,"<answer>The similar distribution of CHIP variant effects between Bloom syndrome patients and controls can be explained by the high background mutation rate in hematopoietic stem cells, leading to frequent occurrence of clonal hematopoiesis, irrespective of the presence of Bloom syndrome.</answer>","The similar distribution of CHIP variant effects between Bloom syndrome patients and controls can be explained by the high background mutation rate in hematopoietic stem cells, leading to frequent occurrence of clonal hematopoiesis, irrespective of the presence of Bloom syndrome.",0,False,True
7718a922-ce2c-4e59-900b-84fe06050ce6,bix-14_q2,What proportion of variants in BLM carriers with VAF < 0.3 are synonymous?,,empty,0.64,"```xml
<answer>Data insufficient to provide a specific proportion of synonymous variants in BLM carriers with VAF < 0.3</answer>
```",Data insufficient to provide a specific proportion of synonymous variants in BLM carriers with VAF < 0.3,0,False,True
7718a922-ce2c-4e59-900b-84fe06050ce6,bix-14_q3,What is the absolute difference in somatic (VAF < 0.3) missense variant frequency between Control Parents and BSyn Probands?,,empty,0.228,"<answer>To determine the absolute difference in somatic (VAF < 0.3) missense variant frequency between Control Parents and BSyn Probands, specific dataset analysis would be required. As the exact numerical data is not provided here, a clear answer cannot be established without further information.</answer>","To determine the absolute difference in somatic (VAF < 0.3) missense variant frequency between Control Parents and BSyn Probands, specific dataset analysis would be required. As the exact numerical data is not provided here, a clear answer cannot be established without further information.",0,False,True
7718a922-ce2c-4e59-900b-84fe06050ce6,bix-14_q4,How does excluding intronic variants affect the total number of CHIP variants in the dataset?,,empty,"Reduces from 11,896 to 4,550 variants","<answer>Excluding intronic variants from the dataset would likely decrease the total number of CHIP (Clonal Hematopoiesis of Indeterminate Potential) variants, as intronic variants, although potentially less impactful on functions than exonic or regulatory variants, contribute to the overall count of genetic variants in a dataset.</answer>","Excluding intronic variants from the dataset would likely decrease the total number of CHIP (Clonal Hematopoiesis of Indeterminate Potential) variants, as intronic variants, although potentially less impactful on functions than exonic or regulatory variants, contribute to the overall count of genetic variants in a dataset.",0,False,True
bda54b38-9b49-4009-aad6-d5f52675438a,bix-16_q1,"What gene has the strongest negative Spearman correlation between its expression and essentiality, in the provided data?",,empty,CDKN1A,<answer>TP53</answer>,TP53,0,False,True
bda54b38-9b49-4009-aad6-d5f52675438a,bix-16_q2,What is the skewness characteristic of the gene expression (log2(TPM+1)) distribution across all cell lines in the dataset?,,empty,Left-skewed with a long tail,"<answer>As the dataset details are not provided, it's not possible to determine the skewness characteristic of the gene expression (log2(TPM+1)) distribution across all cell lines. Typically, one would need to compute the skewness statistically from the data provided.</answer>","As the dataset details are not provided, it's not possible to determine the skewness characteristic of the gene expression (log2(TPM+1)) distribution across all cell lines. Typically, one would need to compute the skewness statistically from the data provided.",0,False,True
bda54b38-9b49-4009-aad6-d5f52675438a,bix-16_q3,How many genes in the provided data show strong positive correlation with a Spearman coefficient >= 0.6?,,empty,3,<answer> I cannot determine the number of genes with strong positive correlation without the provided data. </answer>,I cannot determine the number of genes with strong positive correlation without the provided data.,0,False,True
bda54b38-9b49-4009-aad6-d5f52675438a,bix-16_q4,"Overall, what percentage of genes show a statistically significant correlation between expression and essentiality?",,empty,21.81%,<answer>20%</answer>,20%,0,False,True
1cf79c8c-fb8c-453c-8788-c8958ab6f152,bix-17_q1,What is the correlation coefficient between total CHIP variants and somatic CHIP variants (VAF < 0.3) in the Bloom syndrome proband cohort?,,empty,0.12,<answer>0.76</answer>,0.76,0,False,True
1cf79c8c-fb8c-453c-8788-c8958ab6f152,bix-17_q2,What is the median number of somatic CHIP variants (VAF < 0.3) in the BLM carrier cohort?,,empty,2.0,<answer>1</answer>,1,0,False,True
1cf79c8c-fb8c-453c-8788-c8958ab6f152,bix-17_q3,What is the F-statistic from ANOVA analysis when comparing CHIP variant frequencies between cohorts after removing intronic variants?,,empty,0.863,<answer> The F-statistic value would depend on the specific data from the ANOVA analysis and cannot be determined without performing the analysis on the given data. </answer>,The F-statistic value would depend on the specific data from the ANOVA analysis and cannot be determined without performing the analysis on the given data.,0,False,True
1cf79c8c-fb8c-453c-8788-c8958ab6f152,bix-17_q4,What percentage of total CHIP variants in control parents have VAF < 0.3?,,empty,0.29%,<answer>My knowledge does not include specific data regarding the percentage of total CHIP variants in control parents with VAF < 0.3. This information might be found in a specific study or dataset.</answer>,My knowledge does not include specific data regarding the percentage of total CHIP variants in control parents with VAF < 0.3. This information might be found in a specific study or dataset.,0,False,True
d59734d2-a3e0-462a-a5fd-c8ddc11392b8,bix-18_q1,"In a P. aeruginosa swarming analysis, what circularity measurement would be most consistent with swarming behavior?",,empty,0.08,"<answer>Low circularity measurement indicates more branching and irregular edges, consistent with swarming behavior.</answer>","Low circularity measurement indicates more branching and irregular edges, consistent with swarming behavior.",1,True,True
d59734d2-a3e0-462a-a5fd-c8ddc11392b8,bix-18_q2,What is the mean swarming area of wildtype P. aeruginosa?,,empty,"82,000","<answer>Data on the mean swarming area of wildtype P. aeruginosa can vary, but a common value cited in literature is approximately 60 mm in diameter under standard laboratory conditions.</answer>","Data on the mean swarming area of wildtype P. aeruginosa can vary, but a common value cited in literature is approximately 60 mm in diameter under standard laboratory conditions.",0,False,True
d59734d2-a3e0-462a-a5fd-c8ddc11392b8,bix-18_q3,What is the approximated reduction in mean colony area for the ΔlasR mutant compared to wildtype?,,empty,70% reduction,<answer> The approximated reduction in mean colony area for the ΔlasR mutant compared to wildtype is not specified in the given context. </answer>,The approximated reduction in mean colony area for the ΔlasR mutant compared to wildtype is not specified in the given context.,0,False,True
d59734d2-a3e0-462a-a5fd-c8ddc11392b8,bix-18_q4,What is the standard error of the mean (SEM) for circularity measurements in the rhlR- mutant?,,empty,0.032,<answer>The standard error of the mean (SEM) for circularity measurements in the rhlR- mutant cannot be determined without specific data. Please provide the data or more context to calculate it.</answer>,The standard error of the mean (SEM) for circularity measurements in the rhlR- mutant cannot be determined without specific data. Please provide the data or more context to calculate it.,0,False,True
d59734d2-a3e0-462a-a5fd-c8ddc11392b8,bix-18_q5,What is the relative proportion of mean colony area of the ΔlasR mutant to the wildtype strain?,,empty,Approximately 25% (1/4) of wildtype,<answer>Data not provided</answer>,Data not provided,0,False,True
d59734d2-a3e0-462a-a5fd-c8ddc11392b8,bix-18_q6,What is the standard error of the mean (SEM) for colony area in the rhlR- mutant strain?,,empty,0.35,<answer> The standard error of the mean (SEM) for colony area in the rhlR- mutant strain is not provided in the question. Additional data or context is needed to calculate or identify it. </answer>,The standard error of the mean (SEM) for colony area in the rhlR- mutant strain is not provided in the question. Additional data or context is needed to calculate or identify it.,0,False,True
8c64b1fa-fdcc-41e2-be8d-2f0c8d5faaa1,bix-19_q1,"Based on the observed effect size in the NeuN count data, how many samples per group would be required to detect a statistically significant difference between KD and CTRL conditions with 80% power?",,empty,337 samples,"<answer>Calculating the required sample size depends on the specific observed effect size, variance, significance level (typically 0.05), and the desired power level (80%). Without specific values, an exact number can't be provided. However, if you have these values, statistical software or power analysis formulas can be used to determine the sample size.</answer>","Calculating the required sample size depends on the specific observed effect size, variance, significance level (typically 0.05), and the desired power level (80%). Without specific values, an exact number can't be provided. However, if you have these values, statistical software or power analysis formulas can be used to determine the sample size.",0,False,True
8c64b1fa-fdcc-41e2-be8d-2f0c8d5faaa1,bix-19_q2,What is the Cohen's d effect size for the difference in NeuN counts between KD and CTRL conditions in the dataset?,,empty,0.216,"<answer>To compute Cohen's d, statistical details such as means and standard deviations for the KD and CTRL conditions are necessary, which are not provided in your request. Therefore, I am unable to output a specific answer without this data.</answer>","To compute Cohen's d, statistical details such as means and standard deviations for the KD and CTRL conditions are necessary, which are not provided in your request. Therefore, I am unable to output a specific answer without this data.",0,False,True
8c64b1fa-fdcc-41e2-be8d-2f0c8d5faaa1,bix-19_q3,What is the Shapiro-Wilk test statistic (W) for the KD group's NeuN count distribution?,,empty,0.956,<answer> The Shapiro-Wilk test statistic (W) for the KD group's NeuN count distribution is not provided in the information given. </answer>,The Shapiro-Wilk test statistic (W) for the KD group's NeuN count distribution is not provided in the information given.,0,False,True
8c64b1fa-fdcc-41e2-be8d-2f0c8d5faaa1,bix-19_q4,What is the F-statistic for the interaction effect between Hemisphere and Sex in the two-way ANOVA analysis?,,empty,1.066,<answer> The F-statistic value is not provided because it is specific to a particular dataset and analysis. </answer>,The F-statistic value is not provided because it is specific to a particular dataset and analysis.,0,False,True
2ccdbe37-0a92-47b5-9bab-fa8a8c470799,bix-20_q1,"What proportion of putatively somatic (VAF < 0.3, exonic) CHIP variants in BSyn Probands can be considered benign?",,empty,0.93,"<answer> I'm sorry, but I don't have access to specific data about CHIP variants in BSyn Probands to determine the proportion that can be considered benign. </answer>","I'm sorry, but I don't have access to specific data about CHIP variants in BSyn Probands to determine the proportion that can be considered benign.",0,False,True
2ccdbe37-0a92-47b5-9bab-fa8a8c470799,bix-20_q2,"What is the proportion of likely benign, exonic variants in the Control Children group for variants with VAF < 0.3?",,empty,0.00,"```xml
<answer>Data not provided</answer>
```",Data not provided,0,False,True
2ccdbe37-0a92-47b5-9bab-fa8a8c470799,bix-20_q3,What is the difference in the proportion of benign exonic variants (VAF < 0.3) between BLM Carriers and BSyn Probands?,,empty,0.017,"```xml
<answer> The proportion difference cannot be determined without specific data. </answer>
```",The proportion difference cannot be determined without specific data.,0,False,True
2ccdbe37-0a92-47b5-9bab-fa8a8c470799,bix-20_q4,What is the total number of pathogenicity categories observed in BLM Carriers after applying the VAF < 0.3 filter?,,empty,2,<answer>Four</answer>,Four,0,False,True
2ccdbe37-0a92-47b5-9bab-fa8a8c470799,bix-20_q5,What is the ratio of benign to likely benign variants in Bloom Syndrome probands for exonic variants with VAF < 0.3?,,empty,13:1,<answer>There is no specific data available on the ratio of benign to likely benign exonic variants with VAF < 0.3 in Bloom Syndrome probands in the public domain as of my last update. Research articles or specific datasets would need to be consulted for precise figures.</answer>,There is no specific data available on the ratio of benign to likely benign exonic variants with VAF < 0.3 in Bloom Syndrome probands in the public domain as of my last update. Research articles or specific datasets would need to be consulted for precise figures.,0,False,True
2ccdbe37-0a92-47b5-9bab-fa8a8c470799,bix-20_q6,"What percentage of putative somatic variants (VAF < 0.3, exonic) are classified as benign in BLM carriers?",,empty,94.6%,<answer>95%</answer>,95%,1,True,True
2ccdbe37-0a92-47b5-9bab-fa8a8c470799,bix-20_q7,"How does filtering for putative somatic variants (VAF < 0.3, exonic) affect the number of pathogenicity categories observed in control children?",,empty,Reduces to 1 category,"<answer>Filtering for putative somatic variants with a variant allele frequency (VAF) of less than 0.3 and focusing on exonic regions would likely decrease the number of pathogenicity categories observed in control children. This is because putative somatic variants are typically rare and may not contribute significantly to pathogenicity in germline contexts, thus reducing the diversity of observed categories.</answer>","Filtering for putative somatic variants with a variant allele frequency (VAF) of less than 0.3 and focusing on exonic regions would likely decrease the number of pathogenicity categories observed in control children. This is because putative somatic variants are typically rare and may not contribute significantly to pathogenicity in germline contexts, thus reducing the diversity of observed categories.",1,True,True
e3bde22d-915c-409b-8646-039e0215b171,bix-21_q1,What rate of saturation accumulation would be expected in a clade of fungi with generation times comparable to animals?,,empty,Lower than typical fungi due to fewer generations per unit time,"<answer>In a clade of fungi with generation times comparable to animals, the rate of saturation accumulation would likely be slower than in fungi with shorter generation times. Fungal clades with longer generation times would accumulate mutations at a rate more similar to animals, reflecting the longer periods between generations.</answer>","In a clade of fungi with generation times comparable to animals, the rate of saturation accumulation would likely be slower than in fungi with shorter generation times. Fungal clades with longer generation times would accumulate mutations at a rate more similar to animals, reflecting the longer periods between generations.",1,True,True
e3bde22d-915c-409b-8646-039e0215b171,bix-21_q2,What is the median saturation value for BUSCO genes in the fungi?,,empty,0.62,<answer>Unknown</answer>,Unknown,0,False,True
e3bde22d-915c-409b-8646-039e0215b171,bix-21_q3,How would including an additional 6 mammalian species affect the average saturation value of the animal dataset?,,empty,Remain within 5% of the original value,"<answer>Including an additional 6 mammalian species would likely affect the average saturation value of the animal dataset, but the specific effect would depend on the saturation values of these new species. If their saturation values are higher than the current average, the overall average would increase; if lower, it would decrease. Without specific saturation values, the exact change cannot be determined.</answer>","Including an additional 6 mammalian species would likely affect the average saturation value of the animal dataset, but the specific effect would depend on the saturation values of these new species. If their saturation values are higher than the current average, the overall average would increase; if lower, it would decrease. Without specific saturation values, the exact change cannot be determined.",0,False,True
e3bde22d-915c-409b-8646-039e0215b171,bix-21_q4,"If ribosomal proteins evolve at 1/3 the rate of metabolic enzymes, what would be the expected ratio of saturation values between these two protein classes in fungi?",,empty,1:3,<answer>3:1</answer>,3:1,0,False,True
e3bde22d-915c-409b-8646-039e0215b171,bix-21_q5,What biological feature of animals likely explains their lower saturation values compared to fungi?,,empty,Longer generation times,"<answer>Animals generally have higher rates of metabolism and oxygen consumption compared to fungi, which likely explains their lower saturation values. Fungi often thrive in environments with varied oxygen availability, and have adaptations for efficient nutrient uptake, while animals' active lifestyles demand higher oxygen utilization and resource consumption.</answer>","Animals generally have higher rates of metabolism and oxygen consumption compared to fungi, which likely explains their lower saturation values. Fungi often thrive in environments with varied oxygen availability, and have adaptations for efficient nutrient uptake, while animals' active lifestyles demand higher oxygen utilization and resource consumption.",0,False,True
34a4ea96-c800-4c11-959e-57cdc4932c52,bix-22_q1,What is the magnitude of correlation between gene length and expression in CD4 T cells when examining only genes with expression values above the median?,,empty,0.05,"<answer>There is no universally established magnitude for the correlation between gene length and expression in CD4 T cells specifically for genes with expression values above the median. The correlation can vary based on the study and dataset used. Generally, such correlations are often calculated within specific research contexts and may require experimental evidence. To obtain this information, a review of specific scientific studies or datasets would be necessary.</answer>","There is no universally established magnitude for the correlation between gene length and expression in CD4 T cells specifically for genes with expression values above the median. The correlation can vary based on the study and dataset used. Generally, such correlations are often calculated within specific research contexts and may require experimental evidence. To obtain this information, a review of specific scientific studies or datasets would be necessary.",0,False,True
34a4ea96-c800-4c11-959e-57cdc4932c52,bix-22_q2,"For genes between 1000-2000 base pairs in length, what is the Pearson correlation coefficient between gene length and expression in CD14 cells?",,empty,0.015,<answer>I do not have specific data regarding the Pearson correlation coefficient between gene length and expression in CD14 cells for genes between 1000-2000 base pairs. This would require specialized data collection and analysis from relevant biological datasets or studies.</answer>,I do not have specific data regarding the Pearson correlation coefficient between gene length and expression in CD14 cells for genes between 1000-2000 base pairs. This would require specialized data collection and analysis from relevant biological datasets or studies.,0,False,True
34a4ea96-c800-4c11-959e-57cdc4932c52,bix-22_q3,What is the difference in correlation coefficients between CD19 and CD14 cells when analyzing genes shorter than 5000 base pairs?,,empty,0.015,"<answer> To provide an answer, specific data analysis would be required which is not accessible in this format. Please conduct the necessary bioinformatics analysis using relevant datasets to obtain the correlation coefficients. </answer>","To provide an answer, specific data analysis would be required which is not accessible in this format. Please conduct the necessary bioinformatics analysis using relevant datasets to obtain the correlation coefficients.",0,False,True
34a4ea96-c800-4c11-959e-57cdc4932c52,bix-22_q4,What is the p-value for the correlation between gene length and expression in CD8 T cells when excluding genes in the bottom quartile of expression?,,empty,7.8 x 10^-9,<answer> The specific p-value cannot be determined without access to the dataset and corresponding statistical analysis results. </answer>,The specific p-value cannot be determined without access to the dataset and corresponding statistical analysis results.,0,False,True
34a4ea96-c800-4c11-959e-57cdc4932c52,bix-22_q5,What is the Pearson correlation coefficient between gene length and expression level in CD4 T cells?,,empty,0.049889,"<answer> The Pearson correlation coefficient between gene length and expression level in CD4 T cells varies depending on the dataset and study. There is no universally agreed-upon value, as it can be influenced by various factors including the specifics of the gene expression data and analysis methods used. Detailed study references would be needed for a precise number. </answer>","The Pearson correlation coefficient between gene length and expression level in CD4 T cells varies depending on the dataset and study. There is no universally agreed-upon value, as it can be influenced by various factors including the specifics of the gene expression data and analysis methods used. Detailed study references would be needed for a precise number.",0,False,True
34a4ea96-c800-4c11-959e-57cdc4932c52,bix-22_q6,Which immune cell type shows the highest correlation coefficent between gene length and expression level?,,empty,CD4,<answer>T cells</answer>,T cells,0,False,True
34a4ea96-c800-4c11-959e-57cdc4932c52,bix-22_q7,What is the p-value for the correlation between gene length and expression in CD14 cells?,,empty,6.140363e-03,<answer> The p-value for the correlation between gene length and expression in CD14 cells is not specified in the prompt. You would need specific experimental data to determine this. </answer>,The p-value for the correlation between gene length and expression in CD14 cells is not specified in the prompt. You would need specific experimental data to determine this.,0,False,True
8690e7cb-7405-4d2a-9721-e85824d05822,bix-23_q1,What is the percent difference in median gap character between fungal and animal multiple sequence alignments?,,empty,33% higher in fungi,"```xml
<answer>5%</answer>
```",5%,0,False,True
8690e7cb-7405-4d2a-9721-e85824d05822,bix-23_q2,What is the median position of the first gap occurrence in fungal BUSCO gene alignments?,,empty,Position 47,"<answer> The median position of the first gap occurrence in fungal BUSCO gene alignments is typically around the 3rd or 4th codon position, depending on the dataset and alignment specifics. </answer>","The median position of the first gap occurrence in fungal BUSCO gene alignments is typically around the 3rd or 4th codon position, depending on the dataset and alignment specifics.",0,False,True
8690e7cb-7405-4d2a-9721-e85824d05822,bix-23_q3,What is the correlation coefficient (using pearson) between original sequence length and number of gaps in animal BUSCO genes?,,empty,0.48,<answer>0.5</answer>,0.5,1,True,True
8690e7cb-7405-4d2a-9721-e85824d05822,bix-23_q4,"In the animal BUSCO gene alignments, what percentage of alignment positions containing gaps show high sequence conservation (>80% identity) in the non-gap sequences?",,empty,24%,<answer>Approximately 9.1%</answer>,Approximately 9.1%,0,False,True
b1b0ef00-cb15-4375-9aac-e1e53a7250c5,bix-24_q1,What specific metabolic pathway enriched in the downregulated DGEs in CBD-treated CRC cells based on enrichment analysis?,,empty,Canonical glycolysis,<answer>Fatty acid metabolism</answer>,Fatty acid metabolism,0,False,True
b1b0ef00-cb15-4375-9aac-e1e53a7250c5,bix-24_q2,What is the predominant direction of gene expression change in CBD-treated CRC cells?,,empty,Downregulation,"<answer>CBD treatment in colorectal cancer (CRC) cells predominantly leads to a downregulation of genes associated with cell proliferation and survival, and an upregulation of genes related to apoptosis and autophagy pathways.</answer>","CBD treatment in colorectal cancer (CRC) cells predominantly leads to a downregulation of genes associated with cell proliferation and survival, and an upregulation of genes related to apoptosis and autophagy pathways.",1,True,True
b1b0ef00-cb15-4375-9aac-e1e53a7250c5,bix-24_q3,How does gene expression change between DMSO and CBD-treated cells?,,empty,No significant difference,"<answer>The gene expression in CBD-treated cells often shows differential expression compared to DMSO-treated cells. CBD can modulate pathways related to inflammation, apoptosis, and oxidative stress, leading to either upregulation or downregulation of specific genes involved in these pathways. The specific changes depend on the cell type and experimental conditions.</answer>","The gene expression in CBD-treated cells often shows differential expression compared to DMSO-treated cells. CBD can modulate pathways related to inflammation, apoptosis, and oxidative stress, leading to either upregulation or downregulation of specific genes involved in these pathways. The specific changes depend on the cell type and experimental conditions.",0,False,True
b1b0ef00-cb15-4375-9aac-e1e53a7250c5,bix-24_q4,How does gene expression change between Untreated and DMSO-treated cells?,,empty,No significant difference,"<answer>Gene expression changes between untreated and DMSO-treated cells can vary depending on the cell type and experimental conditions. DMSO, often used as a solvent in biological experiments, can induce changes in gene expression by affecting cell membrane permeability, cellular signaling pathways, and stress response genes. In some cases, DMSO may have minimal impact, while in others, it can lead to significant transcriptional changes. Specific genes that respond to DMSO treatment are context-dependent and should be identified through gene expression profiling techniques like RNA sequencing or microarrays.</answer>","Gene expression changes between untreated and DMSO-treated cells can vary depending on the cell type and experimental conditions. DMSO, often used as a solvent in biological experiments, can induce changes in gene expression by affecting cell membrane permeability, cellular signaling pathways, and stress response genes. In some cases, DMSO may have minimal impact, while in others, it can lead to significant transcriptional changes. Specific genes that respond to DMSO treatment are context-dependent and should be identified through gene expression profiling techniques like RNA sequencing or microarrays.",0,False,True
b1b0ef00-cb15-4375-9aac-e1e53a7250c5,bix-24_q5,What evidence from a pathway enrichment analysis of CBD-treated CRC cells supports metabolic dysregulation?,,empty,Multiple metabolic pathways including glycolysis and glucose catabolism are among the most significantly enriched downregulated processes,"<answer>In a pathway enrichment analysis of CBD-treated colorectal cancer (CRC) cells, evidence supporting metabolic dysregulation includes the significant enrichment of pathways related to altered glucose and lipid metabolism. Notable pathways may include glycolysis, gluconeogenesis, fatty acid biosynthesis, and TCA cycle, indicating disruptions in energy production and biosynthesis.</answer>","In a pathway enrichment analysis of CBD-treated colorectal cancer (CRC) cells, evidence supporting metabolic dysregulation includes the significant enrichment of pathways related to altered glucose and lipid metabolism. Notable pathways may include glycolysis, gluconeogenesis, fatty acid biosynthesis, and TCA cycle, indicating disruptions in energy production and biosynthesis.",1,True,True
b1b0ef00-cb15-4375-9aac-e1e53a7250c5,bix-24_q6,What biological process shows the most significant enrichment (lowest adjusted p-value) in the CBD treatment setting across/using all genes?,,empty,Cellular response to decreased oxygen levels,"<answer>Based on typical enrichment analysis results that might be available, a likely biological process with significant enrichment under CBD treatment could be ""response to oxidative stress"" or ""inflammatory response"". However, to provide an accurate answer, specific experimental data and corresponding enrichment analysis results are necessary.</answer>","Based on typical enrichment analysis results that might be available, a likely biological process with significant enrichment under CBD treatment could be ""response to oxidative stress"" or ""inflammatory response"". However, to provide an accurate answer, specific experimental data and corresponding enrichment analysis results are necessary.",0,False,True
b1b0ef00-cb15-4375-9aac-e1e53a7250c5,bix-24_q7,How are genes involved in the glycolysis pathway regulated in CBD-treated CRC cells?,,empty,"Predominantly downregulated with genes like GPI, PGK1, and ALDOC","<answer>CBD treatment in colorectal cancer (CRC) cells may alter the expression of genes involved in the glycolysis pathway, potentially leading to changes in metabolic activity. The regulation can be through transcriptional and post-transcriptional mechanisms, possibly involving signaling pathways that are modulated by CBD, such as PI3K/AKT or AMPK pathways. However, specific genes and their regulatory patterns can vary depending on the study and cell line used, and further research is needed for detailed insights.</answer>","CBD treatment in colorectal cancer (CRC) cells may alter the expression of genes involved in the glycolysis pathway, potentially leading to changes in metabolic activity. The regulation can be through transcriptional and post-transcriptional mechanisms, possibly involving signaling pathways that are modulated by CBD, such as PI3K/AKT or AMPK pathways. However, specific genes and their regulatory patterns can vary depending on the study and cell line used, and further research is needed for detailed insights.",0,False,True
964b67db-88d8-4286-9995-10ccc6ba4c39,bix-25_q1,What is the median treeness/RCV value for fungal genes in the dataset?,,empty,0.26,"```xml
<answer> The median treeness/RCV value is not available without access to the specific dataset. </answer>
```",The median treeness/RCV value is not available without access to the specific dataset.,0,False,True
964b67db-88d8-4286-9995-10ccc6ba4c39,bix-25_q2,What is the correlation coefficient between gene alignment length and treeness/RCV values in the dataset?,,empty,0.08,"<answer> The correlation coefficient between gene alignment length and treeness/RCV values in the dataset is not explicitly provided. You would need to calculate it using statistical software or a programming language like Python or R by applying a function like `pearsonr` from Scipy in Python or `cor()` in R, assuming you have the dataset available. </answer>","The correlation coefficient between gene alignment length and treeness/RCV values in the dataset is not explicitly provided. You would need to calculate it using statistical software or a programming language like Python or R by applying a function like `pearsonr` from Scipy in Python or `cor()` in R, assuming you have the dataset available.",0,False,True
964b67db-88d8-4286-9995-10ccc6ba4c39,bix-25_q3,What percentage of single-copy orthologous genes show treeness/RCV values above 0.4 in both animals and fungi?,,empty,15%,"```xml
<answer>64%</answer>
```",64%,0,False,True
964b67db-88d8-4286-9995-10ccc6ba4c39,bix-25_q4,What is the maximum treeness/RCV value observed in genes with greater than 70% alignment gaps?,,empty,0.21,"```xml
<answer> The maximum treeness/RCV value is not specified based on the given data. Please provide additional specific data or context. </answer>
```",The maximum treeness/RCV value is not specified based on the given data. Please provide additional specific data or context.,0,False,True
0923d260-fe1b-4fb4-4398-79edf546e584,bix-26_q1,"In the iron-depleted glucose medium, what KEGG pathway enrichment pattern, using over-representation analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05), provides direct evidence for environment-specific bacterial responses?",,empty,Exclusive enrichment of cyanoamino acid metabolism in downregulated genes,"```xml
<answer>In the iron-depleted glucose medium, an over-representation analysis might show enrichment in pathways such as the siderophore biosynthesis pathway, ABC transporters involved in iron uptake, and glycolysis/gluconeogenesis, indicating bacterial adaptation to iron scarcity and a shift in metabolic strategies to optimize nutrient utilization under glucose-available conditions.</answer>
```","In the iron-depleted glucose medium, an over-representation analysis might show enrichment in pathways such as the siderophore biosynthesis pathway, ABC transporters involved in iron uptake, and glycolysis/gluconeogenesis, indicating bacterial adaptation to iron scarcity and a shift in metabolic strategies to optimize nutrient utilization under glucose-available conditions.",0,False,True
0923d260-fe1b-4fb4-4398-79edf546e584,bix-26_q2,"What is the approximate adjusted p-value for the least significantly enriched KEGG pathway, using over-representation analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05), in the succinate media condition's upregulated gene set?",,empty,0.015,"<answer> The specific adjusted p-value for the least significantly enriched KEGG pathway in the succinate media condition's upregulated gene set is not available, as it depends on the data and analysis context not provided in the question. To obtain this value, one would need to analyze experimental data pertinent to the conditions specified. </answer>","The specific adjusted p-value for the least significantly enriched KEGG pathway in the succinate media condition's upregulated gene set is not available, as it depends on the data and analysis context not provided in the question. To obtain this value, one would need to analyze experimental data pertinent to the conditions specified.",0,False,True
0923d260-fe1b-4fb4-4398-79edf546e584,bix-26_q3,"Approximately how many genes contribute to the ABC transporters pathway enrichment in over-representation analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05) in the iron-depleted glucose condition?",,empty,10 genes,<answer>Approximately 25 genes contribute to the ABC transporters pathway enrichment under the specified conditions.</answer>,Approximately 25 genes contribute to the ABC transporters pathway enrichment under the specified conditions.,0,False,True
0923d260-fe1b-4fb4-4398-79edf546e584,bix-26_q4,"How many KEGG pathways, using over-representation analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05), show significant downregulation in both succinate and iron-depleted glucose media conditions?",,empty,5 pathways,"```xml
<answer>0</answer>
```",0,0,False,True
0923d260-fe1b-4fb4-4398-79edf546e584,bix-26_q5,"In a KEGG pathway enrichment (over-representation) analysis (logfold cutoff 1.5 or -1.5, adjusted p-value cutoff 0.05), of P. aeruginosa gene expression, how many pathways shows significant enrichment specifically in iron-depleted conditions but not in succinate media?",,empty,3,"```xml
<answer>4</answer>
```",4,0,False,True
0923d260-fe1b-4fb4-4398-79edf546e584,bix-26_q6,What is the number of genes involved in the least significantly enriched pathway (largest significant adjusted p-value) in iron-depleted conditions?,,empty,18 genes,"```xml
<answer> I do not have access to specific datasets or results from experiments, including details about gene enrichment in particular conditions. </answer>
```","I do not have access to specific datasets or results from experiments, including details about gene enrichment in particular conditions.",0,False,True
0923d260-fe1b-4fb4-4398-79edf546e584,bix-26_q7,What is the adjusted p-value threshold used to determine significant pathway enrichment in the KEGG over-representation analysis?,,empty,0.05,<answer>0.05</answer>,0.05,1,True,True
0f14ffa7-f02a-4d20-8142-dfc404195e56,bix-27_q1,What is the adjusted rand index (ARI) value when comparing train and test consensus clusters in the experimental dataset with 3 clusters?,,empty,0.906,<answer> The adjusted rand index (ARI) value is not provided in the prompt and cannot be determined without the experimental dataset or additional information. </answer>,The adjusted rand index (ARI) value is not provided in the prompt and cannot be determined without the experimental dataset or additional information.,0,False,True
0f14ffa7-f02a-4d20-8142-dfc404195e56,bix-27_q2,How many samples are consistently classified into the same cluster across both training and test consensus clustering with 3 clusters?,,empty,173,"<answer> The specific number of samples consistently classified into the same cluster is not provided in the question, and additional data or context is needed to determine this number. </answer>","The specific number of samples consistently classified into the same cluster is not provided in the question, and additional data or context is needed to determine this number.",0,False,True
0f14ffa7-f02a-4d20-8142-dfc404195e56,bix-27_q3,What is the predominant biological process enriched in genes specific to cluster 0?,,empty,Oxidative phosphorylation,"<answer>Without specific context or data on cluster 0, it's not possible to determine the predominant biological process enriched in its genes. Typically, one would need data analysis results from bioinformatics tools to provide this information.</answer>","Without specific context or data on cluster 0, it's not possible to determine the predominant biological process enriched in its genes. Typically, one would need data analysis results from bioinformatics tools to provide this information.",0,False,True
0f14ffa7-f02a-4d20-8142-dfc404195e56,bix-27_q4,What percentage of genes identified as specific to cluster 1 (using a logistic regression coefficient threshold of 1.5) are associated with druggable targets in ChEMBL?,,empty,5%,<answer>Data specific to the percentage of genes identified as specific to cluster 1 associated with druggable targets in ChEMBL is not available in the knowledge base. Please refer to relevant databases or literature for accurate figures.</answer>,Data specific to the percentage of genes identified as specific to cluster 1 associated with druggable targets in ChEMBL is not available in the knowledge base. Please refer to relevant databases or literature for accurate figures.,0,False,True
0f14ffa7-f02a-4d20-8142-dfc404195e56,bix-27_q5,What adjusted rand index (ARI) value indicates that Alzheimer's disease patient subtypes are more stable than random clustering?,,empty,ARI > 0.80,<answer>ARI value greater than 0</answer>,ARI value greater than 0,0,False,True
0f14ffa7-f02a-4d20-8142-dfc404195e56,bix-27_q6,What is the optimal number of clusters for patient stratification based on normalized mutual information (NMI) values?,,empty,3 clusters (NMI = 0.868),"<answer>Determining the optimal number of clusters for patient stratification based on normalized mutual information (NMI) values requires analyzing the NMI scores for different clustering solutions. The optimal number is typically the one that maximizes NMI, indicating the best balance between cluster cohesion and separation. It cannot be specified without data.</answer>","Determining the optimal number of clusters for patient stratification based on normalized mutual information (NMI) values requires analyzing the NMI scores for different clustering solutions. The optimal number is typically the one that maximizes NMI, indicating the best balance between cluster cohesion and separation. It cannot be specified without data.",0,False,True
0f14ffa7-f02a-4d20-8142-dfc404195e56,bix-27_q7,Which biological pathway characterizes the first identified patient subtype (Cluster 0)?,,empty,Oxidative phosphorylation,"<answer>Without specific details about the study or condition being referred to, I cannot accurately determine which biological pathway characterizes ""Cluster 0"". Please provide more context or details.</answer>","Without specific details about the study or condition being referred to, I cannot accurately determine which biological pathway characterizes ""Cluster 0"". Please provide more context or details.",0,False,True
c66d3ed9-0a95-46be-a237-ed68498ea7f6,bix-28_q1,What p-value was obtained when comparing median long branch scores between fungi and animals?,,empty,5.107 x 10^-47,<answer>0.003</answer>,0.003,0,False,True
c66d3ed9-0a95-46be-a237-ed68498ea7f6,bix-28_q2,What is the median value for fungal mean long branch scores in the dataset?,,empty,-25.0000,<answer>Median value is not specified as the dataset is not provided.</answer>,Median value is not specified as the dataset is not provided.,0,False,True
c66d3ed9-0a95-46be-a237-ed68498ea7f6,bix-28_q3,What is the median long branch score for the BUSCO gene 996662at2759 in fungi?,,empty,-30.4551,"```xml
<answer> Not available </answer>
```",Not available,0,False,True
c66d3ed9-0a95-46be-a237-ed68498ea7f6,bix-28_q4,What is the Mann-Whitney U statistic when comparing mean long branch scores between animals and fungi?,,empty,4639.0,"<answer>The Mann-Whitney U statistic requires specific data to calculate, which is not provided in the question. Therefore, it is not possible to determine the U statistic for the mean long branch scores between animals and fungi. More specific data would be needed for an accurate computation.</answer>","The Mann-Whitney U statistic requires specific data to calculate, which is not provided in the question. Therefore, it is not possible to determine the U statistic for the mean long branch scores between animals and fungi. More specific data would be needed for an accurate computation.",0,False,True
c66d3ed9-0a95-46be-a237-ed68498ea7f6,bix-28_q5,What is the average median long branch score for fungal sequences?,,empty,-26.9,<answer>There is no widely recognized average median long branch score for fungal sequences as it can vary depending on the dataset and methodology used in different studies. It's advisable to refer to specific research articles or databases for this information.</answer>,There is no widely recognized average median long branch score for fungal sequences as it can vary depending on the dataset and methodology used in different studies. It's advisable to refer to specific research articles or databases for this information.,0,False,True
c66d3ed9-0a95-46be-a237-ed68498ea7f6,bix-28_q6,What is the absolute difference in average mean long branch scores between animals and fungi?,,empty,5.2,"```xml
<answer>0.024</answer>
```",0.024,0,False,True
b8c485ff-d146-4162-9403-9593c8847cfe,bix-29_q1,What is the effect of BCG vaccination on COVID-19 severity when controlling for prior medical history count?,,empty,Increases severity with odds ratio 1.63,"<answer>The effect of BCG vaccination on COVID-19 severity, when controlling for prior medical history count, remains inconclusive. Some studies suggest potential protective effects, while others find no significant impact. Further research is needed to clarify this relationship.</answer>","The effect of BCG vaccination on COVID-19 severity, when controlling for prior medical history count, remains inconclusive. Some studies suggest potential protective effects, while others find no significant impact. Further research is needed to clarify this relationship.",0,False,True
b8c485ff-d146-4162-9403-9593c8847cfe,bix-29_q2,What is the independent effect of each additional ongoing medical condition on COVID-19 severity?,,empty,35% increase in odds of higher severity,"<answer>Each additional ongoing medical condition independently increases the risk of severe COVID-19 outcomes, including hospitalization, requiring intensive care, and mortality. The risk is cumulative, meaning that having multiple conditions can significantly compound this risk, as they may exacerbate the severity of the infection by impacting immune response and other physiological systems.</answer>","Each additional ongoing medical condition independently increases the risk of severe COVID-19 outcomes, including hospitalization, requiring intensive care, and mortality. The risk is cumulative, meaning that having multiple conditions can significantly compound this risk, as they may exacerbate the severity of the infection by impacting immune response and other physiological systems.",1,True,True
b8c485ff-d146-4162-9403-9593c8847cfe,bix-29_q3,How does the interaction between BCG vaccination and prior medical history affect COVID-19 severity?,,empty,No significant interaction effect (OR≈1.0),"<answer>Studies have suggested that the Bacillus Calmette-Guérin (BCG) vaccination might confer some level of non-specific protection against COVID-19, potentially reducing severity. However, its impact can vary based on an individual's medical history, such as the presence of comorbidities that influence immune response. Hence, while BCG vaccination may offer some benefit, its interaction with past medical history necessitates individualized consideration, and more research is needed for conclusive evidence.</answer>","Studies have suggested that the Bacillus Calmette-Guérin (BCG) vaccination might confer some level of non-specific protection against COVID-19, potentially reducing severity. However, its impact can vary based on an individual's medical history, such as the presence of comorbidities that influence immune response. Hence, while BCG vaccination may offer some benefit, its interaction with past medical history necessitates individualized consideration, and more research is needed for conclusive evidence.",0,False,True
b8c485ff-d146-4162-9403-9593c8847cfe,bix-29_q4,What is the impact of patient interaction frequency on COVID-19 severity among healthcare workers?,,empty,No significant effect on severity (OR≈1.02),"<answer>Increased patient interaction frequency among healthcare workers is associated with a higher risk of COVID-19 exposure and potential severity, due to greater likelihood of encountering infectious individuals and viral load.</answer>","Increased patient interaction frequency among healthcare workers is associated with a higher risk of COVID-19 exposure and potential severity, due to greater likelihood of encountering infectious individuals and viral load.",0,False,True
3d4eb7bb-4fbc-4300-b79a-3eba7a6221bc,bix-30_q1,What percentage of the analyzed miRNAs show significant differential expression (p ≤ 0.05) before multiple testing correction?,,empty,28%,<answer> The percentage of analyzed miRNAs showing significant differential expression before multiple testing correction is not provided in the prompt. </answer>,The percentage of analyzed miRNAs showing significant differential expression before multiple testing correction is not provided in the prompt.,0,False,True
3d4eb7bb-4fbc-4300-b79a-3eba7a6221bc,bix-30_q2,How many miRNAs remain significant at p ≤ 0.05 after Benjamini-Hochberg correction?,,empty,0,<answer> The number of significant miRNAs depends on your specific dataset and the results from your initial statistical tests. You would need to apply the Benjamini-Hochberg procedure to your p-values to determine this number.</answer>,The number of significant miRNAs depends on your specific dataset and the results from your initial statistical tests. You would need to apply the Benjamini-Hochberg procedure to your p-values to determine this number.,0,False,True
3d4eb7bb-4fbc-4300-b79a-3eba7a6221bc,bix-30_q3,What is the ratio of significant miRNAs (p ≤ 0.05) identified using Bonferroni correction compared to Benjamini-Yekutieli correction?,,empty,0:0,"```xml
<answer>The ratio of significant miRNAs identified using Bonferroni correction compared to Benjamini-Yekutieli correction is generally lower, as the Bonferroni method is more conservative and likely to produce fewer significant results.</answer>
```","The ratio of significant miRNAs identified using Bonferroni correction compared to Benjamini-Yekutieli correction is generally lower, as the Bonferroni method is more conservative and likely to produce fewer significant results.",0,False,True
3d4eb7bb-4fbc-4300-b79a-3eba7a6221bc,bix-30_q4,"For miR-95, what percentage of control samples contain valid (non-NA) expression measurements?",,empty,80%,"```xml
<answer> I do not have specific dataset information for miR-95 to provide an exact percentage of control samples with valid expression measurements. </answer>
```",I do not have specific dataset information for miR-95 to provide an exact percentage of control samples with valid expression measurements.,0,False,True
3d4eb7bb-4fbc-4300-b79a-3eba7a6221bc,bix-30_q5,"How many miRNAs maintain statistical significance (p ≤ 0.05) after applying all three methods of multiple testing correction (Benjamini-Hochberg, Benjamini-Yekutieli, and Bonferroni)?",,empty,0 miRNAs,<answer> The information required to determine the number of miRNAs that maintain statistical significance after applying all three methods of multiple testing correction is not provided. </answer>,The information required to determine the number of miRNAs that maintain statistical significance after applying all three methods of multiple testing correction is not provided.,0,False,True
3d4eb7bb-4fbc-4300-b79a-3eba7a6221bc,bix-30_q6,What is the effect of log2 transformation on the number of miRNAs showing significant differences (p ≤ 0.05) between patients and controls before multiple testing correction?,,empty,49 miRNAs show significance,"<answer>Log2 transformation can stabilize variance and normalize data, potentially leading to a more accurate identification of miRNAs with significant differences. However, it doesn't inherently increase the number of miRNAs showing significance; rather, it may improve the reliability of those identified as significant before correction.</answer>","Log2 transformation can stabilize variance and normalize data, potentially leading to a more accurate identification of miRNAs with significant differences. However, it doesn't inherently increase the number of miRNAs showing significance; rather, it may improve the reliability of those identified as significant before correction.",0,False,True
3d4eb7bb-4fbc-4300-b79a-3eba7a6221bc,bix-30_q7,What is the impact on the statistical analysis when samples P_3 and C_18 are included in the dataset?,,empty,The number of significant miRNAs decreases to 35,"<answer>Including samples P_3 and C_18 in the dataset can affect statistical analysis by potentially altering the mean, variance, and trends within the data. It may introduce or mitigate bias, change outlier status, and affect the power of statistical tests, depending on the characteristics of these samples compared to the existing dataset.</answer>","Including samples P_3 and C_18 in the dataset can affect statistical analysis by potentially altering the mean, variance, and trends within the data. It may introduce or mitigate bias, change outlier status, and affect the power of statistical tests, depending on the characteristics of these samples compared to the existing dataset.",0,False,True
b1dbace7-f6e9-42ec-81e1-bcc24161cc27,bix-31_q1,What is the t-statistic value when comparing sex-specific differential expression between protein-coding genes in CD4/CD8 cells versus other cell types?,,empty,18.93,<answer> The specific t-statistic value for comparing sex-specific differential expression between protein-coding genes in CD4/CD8 cells versus other cell types is not provided in the available data. The t-statistic value would be derived from a specific statistical analysis using relevant gene expression data. </answer>,The specific t-statistic value for comparing sex-specific differential expression between protein-coding genes in CD4/CD8 cells versus other cell types is not provided in the available data. The t-statistic value would be derived from a specific statistical analysis using relevant gene expression data.,0,False,True
b1dbace7-f6e9-42ec-81e1-bcc24161cc27,bix-31_q2,"By performing a sex-specific differential expression analysis of protein-coding genes, what is the adjusted p-value of FAM138A?",,empty,,"<answer>To provide the adjusted p-value of FAM138A from a sex-specific differential expression analysis, specific study data is needed, which I do not have access to. Therefore, I am unable to supply an exact value. Consider consulting the relevant study or database for precise information.</answer>","To provide the adjusted p-value of FAM138A from a sex-specific differential expression analysis, specific study data is needed, which I do not have access to. Therefore, I am unable to supply an exact value. Consider consulting the relevant study or database for precise information.",1,True,True
b1dbace7-f6e9-42ec-81e1-bcc24161cc27,bix-31_q3,"How many genes show significant differential expression (padj < 0.05, |log2FoldChange| > 0.5) between males and females specifically in CD4/CD8 cells?",,empty,197,<answer>Information Not Available</answer>,Information Not Available,0,False,True
b1dbace7-f6e9-42ec-81e1-bcc24161cc27,bix-31_q4,What is the p-value for the comparison of sex-specific differential expression between protein-coding and non-protein-coding genes in CD4/CD8 cells?,,empty,6.50e-01,<answer> The p-value for the comparison of sex-specific differential expression between protein-coding and non-protein-coding genes in CD4/CD8 cells is not specified in the provided information. </answer>,The p-value for the comparison of sex-specific differential expression between protein-coding and non-protein-coding genes in CD4/CD8 cells is not specified in the provided information.,0,False,True
b1dbace7-f6e9-42ec-81e1-bcc24161cc27,bix-31_q5,What is the p-value obtained when comparing log-fold changes between protein-coding and non-protein-coding genes within CD4/CD8 cells?,,empty,6.50e-01,<answer> The p-value for the comparison is not provided in the given context. </answer>,The p-value for the comparison is not provided in the given context.,0,False,True
a94b7008-bb9a-4a46-ebfb-4afdfdd299d5,bix-32_q1,"Based on the KEGG enrichment analysis (over-representation analysis), how many distinct functional categories (metabolism, signaling, cellular processes) show significant enrichment (adjusted p-value < 0.05) in upregulated genes (logfold > 1.5) in strain 97 relative to strain 1?",,empty,4 functional categories,"```xml
<answer>3</answer>
```",3,0,False,True
a94b7008-bb9a-4a46-ebfb-4afdfdd299d5,bix-32_q2,"How many metabolic pathways are exclusively significantly enriched (regardless of direction of regulation) in the ΔlasIΔrhlI double mutant (strain 99) but not in either of the single mutants (strain 97 and 98), relative to wildtype (strain 1)?",,empty,3,<answer>6</answer>,6,0,False,True
a94b7008-bb9a-4a46-ebfb-4afdfdd299d5,bix-32_q3,"What is the regulatory direction of biofilm formation pathway genes in the ΔlasI mutant (strain 98) relative to wildtype (strain 1), using KEGG enrichment (over-representation analysis)?",,empty,No significant change,"<answer>The regulatory direction of biofilm formation pathway genes in the ΔlasI mutant (strain 98) relative to wildtype (strain 1), using KEGG enrichment analysis, typically shows an upregulation in genes associated with biofilm production due to the compromised quorum sensing system, as LasI is responsible for the synthesis of signaling molecules.</answer>","The regulatory direction of biofilm formation pathway genes in the ΔlasI mutant (strain 98) relative to wildtype (strain 1), using KEGG enrichment analysis, typically shows an upregulation in genes associated with biofilm production due to the compromised quorum sensing system, as LasI is responsible for the synthesis of signaling molecules.",0,False,True
a94b7008-bb9a-4a46-ebfb-4afdfdd299d5,bix-32_q4,"How many enriched pathways using KEGG enrichment (over-representation analysis) are significantly enriched in all three mutant strains (97, 98, and 99), relative to wildtype (strain 1), in the same direction (either upregulated or downregulated)?",,empty,2 pathways,"```xml
<answer> 5 </answer>
```",5,0,False,True
a94b7008-bb9a-4a46-ebfb-4afdfdd299d5,bix-32_q5,"In a KEGG pathway enrichment over-representation analysis (adjusted p-value < 0.05, and logfold > 1.5) of quorum sensing mutants, what two functional categories are exclusively upregulated in the double knockout strain 99 (ΔlasIΔrhlI) strain and not in the single knockouts (strains 97 and 98), relative to wildtype (strain 1)?",,empty,"Ribosome, riboflavin metabolism","```xml
<answer> <category1>Biofilm Formation</category1> <category2>Motility and Chemotaxis</category2> </answer>
```",<category1>Biofilm Formation</category1> <category2>Motility and Chemotaxis</category2>,0,False,True
a94b7008-bb9a-4a46-ebfb-4afdfdd299d5,bix-32_q6,"What two cellular process pathways show consistent enrichment using KEGG over-representation analysis (adjusted p-value < 0.05) across all three quorum sensing mutant strains (97, 98, 99), relative to wildtype (strain 1)?",,empty,"Biosynthesis of secondary metabolites, nitrogen cycle","```xml
<answer>Two cellular process pathways consistently enriched are ""Bacterial chemotaxis"" and ""Flagellar assembly"".</answer>
```","Two cellular process pathways consistently enriched are ""Bacterial chemotaxis"" and ""Flagellar assembly"".",0,False,True
a94b7008-bb9a-4a46-ebfb-4afdfdd299d5,bix-32_q7,"Which metabolic pathway shows the least significant enrichment (highest p.adjust value) in the ΔlasI (strain #98), relative to wildtype (strain 1), mutant in KEGG over-representation analysis?",,empty,"Valine, leucine and isoleucine degradation","```xml
<answer>Information regarding the KEGG over-representation analysis outcomes for ΔlasI (strain #98) relative to wildtype (strain 1) is not available in the provided data. Therefore, the metabolic pathway with the least significant enrichment cannot be determined without specific data inputs.</answer>
```","Information regarding the KEGG over-representation analysis outcomes for ΔlasI (strain #98) relative to wildtype (strain 1) is not available in the provided data. Therefore, the metabolic pathway with the least significant enrichment cannot be determined without specific data inputs.",0,False,True
a5fba1a0-ad42-41da-a299-201655a5ffe8,bix-33_q1,"By performing a gene expression analysis of peripheral immune cells, what conclusion can be drawn about the hypothesis that AAV9 mini-dystrophin treatment leads to downregulation of anti-inflammatory pathways?",,empty,The hypothesis is not supported as no significant downregulation of anti-inflammatory pathways was observed,"<answer>Gene expression analysis of peripheral immune cells can reveal the impact of AAV9 mini-dystrophin treatment on anti-inflammatory pathways. If findings indicate reduced expression of genes associated with anti-inflammatory pathways, it supports the hypothesis of downregulation. Conversely, unchanged or upregulated expression would refute it. </answer>","Gene expression analysis of peripheral immune cells can reveal the impact of AAV9 mini-dystrophin treatment on anti-inflammatory pathways. If findings indicate reduced expression of genes associated with anti-inflammatory pathways, it supports the hypothesis of downregulation. Conversely, unchanged or upregulated expression would refute it.",0,False,True
a5fba1a0-ad42-41da-a299-201655a5ffe8,bix-33_q2,Which immune cell type showed the most significant changes in gene expression following AAV9 mini-dystrophin treatment?,,empty,CD14 Monocytes,<answer>Macrophages</answer>,Macrophages,0,False,True
a5fba1a0-ad42-41da-a299-201655a5ffe8,bix-33_q3,What pattern was observed in the expression of key anti-inflammatory genes following treatment?,,empty,Selective upregulation in CD14 monocytes only,"<answer>Following treatment, an upregulation or increased expression of key anti-inflammatory genes was typically observed, indicating a reduction in inflammatory responses.</answer>","Following treatment, an upregulation or increased expression of key anti-inflammatory genes was typically observed, indicating a reduction in inflammatory responses.",0,False,True
a5fba1a0-ad42-41da-a299-201655a5ffe8,bix-33_q4,What did the pathway analysis reveal about inflammatory responses in immune cells after treatment?,,empty,Activation of inflammatory response in specific cell types,"<answer>The pathway analysis revealed that inflammatory responses in immune cells were significantly modulated after treatment, indicating altered activity in pathways associated with cytokine signaling and immune cell activation.</answer>","The pathway analysis revealed that inflammatory responses in immune cells were significantly modulated after treatment, indicating altered activity in pathways associated with cytokine signaling and immune cell activation.",1,True,True
a5fba1a0-ad42-41da-a299-201655a5ffe8,bix-33_q5,What is the direction of change for IL10 expression in CD14 monocytes after treatment?,,empty,Significant upregulation (log2FC = 0.35),<answer>IL10 expression in CD14 monocytes typically increases after treatment.</answer>,IL10 expression in CD14 monocytes typically increases after treatment.,1,True,True
a5fba1a0-ad42-41da-a299-201655a5ffe8,bix-33_q6,How many peripheral immune cell types show significant differential expression (adjusted p-value < 0.05) of SOCS3?,,empty,1,<answer>Four</answer>,Four,0,False,True
a5fba1a0-ad42-41da-a299-201655a5ffe8,bix-33_q7,"Using GSEA, which cell type shows most significant enrichment of the GO biological process term 'inflammatory response'?",,empty,CD14 Monocytes (p < 0.0001),<answer>Macrophages</answer>,Macrophages,0,False,True
17baa727-5eb7-4544-a466-3148a48b3cde,bix-34_q1,What is the average mean patristic distance for fungal genes in the dataset?,,empty,1.67,"<answer> The average mean patristic distance for fungal genes in the dataset is not provided, as I do not have access to specific datasets. </answer>","The average mean patristic distance for fungal genes in the dataset is not provided, as I do not have access to specific datasets.",0,False,True
17baa727-5eb7-4544-a466-3148a48b3cde,bix-34_q2,What is the median patristic distance for the gene 981902at2759 in fungi?,,empty,2.63,"```xml
<answer> Data not available </answer>
```",Data not available,0,False,True
17baa727-5eb7-4544-a466-3148a48b3cde,bix-34_q3,What is the U-statistic value from the Mann-Whitney U test comparing mean patristic distances between animals and fungi?,,empty,3516.0,<answer> The U-statistic value from the Mann-Whitney U test comparing mean patristic distances between animals and fungi is not provided in the given data. </answer>,The U-statistic value from the Mann-Whitney U test comparing mean patristic distances between animals and fungi is not provided in the given data.,0,False,True
17baa727-5eb7-4544-a466-3148a48b3cde,bix-34_q4,What is the difference between the highest and lowest mean patristic distances among animal genes in the dataset?,,empty,1.94,"```xml
<answer>0.81</answer>
```",0.81,0,False,True
17baa727-5eb7-4544-a466-3148a48b3cde,bix-34_q5,What is the ratio of the median mean patristic distances between fungi and animals for orthologous genes?,,empty,1.95,"<answer> Research indicates that the median mean patristic distance ratio between fungi and animals for orthologous genes is typically around 1:1. This means that on average, evolutionary distances measured through orthologous genes are comparable between the two groups. Exact values might vary depending on specific gene selection or datasets used in the analyses. </answer>","Research indicates that the median mean patristic distance ratio between fungi and animals for orthologous genes is typically around 1:1. This means that on average, evolutionary distances measured through orthologous genes are comparable between the two groups. Exact values might vary depending on specific gene selection or datasets used in the analyses.",0,False,True
17baa727-5eb7-4544-a466-3148a48b3cde,bix-34_q6,What is the average mean patristic distance among orthologous genes in the animal dataset?,,empty,0.91,"```xml
<answer>0.121</answer>
```",0.121,0,False,True
4cb6f8ce-4d81-40b2-8d9c-85868796ee73,bix-35_q1,What pattern in the phylogenetic tree branch lengths would provide direct evidence for accelerated evolution in fungi compared to animals?,,empty,Longer average branch lengths in fungal trees,"<answer>An increased branch length for fungi compared to animals on the phylogenetic tree would provide direct evidence for accelerated evolution in fungi, indicating a higher rate of genetic divergence over time.</answer>","An increased branch length for fungi compared to animals on the phylogenetic tree would provide direct evidence for accelerated evolution in fungi, indicating a higher rate of genetic divergence over time.",1,True,True
4cb6f8ce-4d81-40b2-8d9c-85868796ee73,bix-35_q2,"When analyzing the BUSCO gene 156083at2759 across the study species, what is its evolutionary rate value in animals?",,empty,0.0471,"```xml
<answer>Data not available</answer>
```",Data not available,0,False,True
4cb6f8ce-4d81-40b2-8d9c-85868796ee73,bix-35_q3,What is the Mann-Whitney U statistic value for the comparison of evolutionary rates between animals and fungi?,,empty,3661,<answer> The Mann-Whitney U statistic value for the comparison of evolutionary rates between animals and fungi is not provided without a specific study or dataset. </answer>,The Mann-Whitney U statistic value for the comparison of evolutionary rates between animals and fungi is not provided without a specific study or dataset.,0,False,True
4cb6f8ce-4d81-40b2-8d9c-85868796ee73,bix-35_q4,What is the highest evolutionary rate observed among all fungal BUSCO genes in the dataset?,,empty,1.8921,"<answer>Due to the lack of specific data on the evolutionary rate of fungal BUSCO genes in your dataset, I cannot provide an exact value or gene. Typically, BUSCO genes are highly conserved, implying a generally slow evolutionary rate, but specific datasets might reveal variations. For precise details, refer to the actual dataset analysis results.</answer>","Due to the lack of specific data on the evolutionary rate of fungal BUSCO genes in your dataset, I cannot provide an exact value or gene. Typically, BUSCO genes are highly conserved, implying a generally slow evolutionary rate, but specific datasets might reveal variations. For precise details, refer to the actual dataset analysis results.",0,False,True
4cb6f8ce-4d81-40b2-8d9c-85868796ee73,bix-35_q5,What is the difference in median evolutionary rate between fungi and animals?,,empty,0.35,"<answer>The estimated median evolutionary rate for fungi is approximately 6.65 x 10^-10 substitutions per site per year, while for animals it is around 2.0 x 10^-9 substitutions per site per year. Therefore, fungi generally have a slower evolutionary rate compared to animals.</answer>","The estimated median evolutionary rate for fungi is approximately 6.65 x 10^-10 substitutions per site per year, while for animals it is around 2.0 x 10^-9 substitutions per site per year. Therefore, fungi generally have a slower evolutionary rate compared to animals.",0,False,True
48181cce-3928-4491-94b4-c23504a6aaa1,bix-36_q1,What F-statistic value from the ANOVA test would indicate strong support for constant miRNA expression across immune cell types?,,empty,F = 0.77,"<answer>A low F-statistic value indicates strong support for constant miRNA expression across immune cell types, suggesting little variance between groups compared to within groups.</answer>","A low F-statistic value indicates strong support for constant miRNA expression across immune cell types, suggesting little variance between groups compared to within groups.",1,True,True
48181cce-3928-4491-94b4-c23504a6aaa1,bix-36_q2,How are the log2 fold changes of the CD4 vs CD8 comparison distributed?,,empty,Approximately normal,"```xml
<answer>The distribution of log2 fold changes typically follows a normal distribution centered around zero, indicating no overall bias towards either CD4 or CD8 expression.</answer>
```","The distribution of log2 fold changes typically follows a normal distribution centered around zero, indicating no overall bias towards either CD4 or CD8 expression.",1,True,True
48181cce-3928-4491-94b4-c23504a6aaa1,bix-36_q3,What is the median log2 fold change between CD14 and CD19 cell types for miRNAs?,,empty,Close to 0,"```xml
<answer>Insufficient information provided</answer>
```",Insufficient information provided,0,False,True
48181cce-3928-4491-94b4-c23504a6aaa1,bix-36_q4,What p-value from the multi-group comparison provides evidence for constant miRNA expression?,,empty,p = 0.57,"<answer>There isn't a specific p-value that universally provides evidence for constant miRNA expression; it generally depends on the context and the significance level set by the study. Typically, a p-value greater than 0.05 might suggest no statistically significant difference, implying potentially constant expression across groups. However, it's crucial to consider the specific study design and criteria. </answer>","There isn't a specific p-value that universally provides evidence for constant miRNA expression; it generally depends on the context and the significance level set by the study. Typically, a p-value greater than 0.05 might suggest no statistically significant difference, implying potentially constant expression across groups. However, it's crucial to consider the specific study design and criteria.",0,False,True
48181cce-3928-4491-94b4-c23504a6aaa1,bix-36_q5,What distribution pattern do the log2 fold changes exhibit across all cell type comparisons?,,empty,Normal,<answer>The log2 fold changes typically exhibit a normal distribution pattern across all cell type comparisons.</answer>,The log2 fold changes typically exhibit a normal distribution pattern across all cell type comparisons.,1,True,True
40cbef03-b5c3-4448-b00f-0ba2965dea9b,bix-37_q1,What statistical evidence from the proteomics data exists for the hypothesized role of ENO1 in bladder cancer?,,empty,ENO1 shows a log2FC of 2.27 but adjusted p-value of 0.226,"<answer>Proteomics studies have shown that ENO1 is overexpressed in bladder cancer tissues compared to normal tissues, suggesting its potential role as a biomarker. Quantitative proteomic analyses, such as mass spectrometry, have revealed significant upregulation of ENO1 in tumor samples. This overexpression correlates with tumor progression and poor prognosis, providing statistical evidence for its involvement in the disease.</answer>","Proteomics studies have shown that ENO1 is overexpressed in bladder cancer tissues compared to normal tissues, suggesting its potential role as a biomarker. Quantitative proteomic analyses, such as mass spectrometry, have revealed significant upregulation of ENO1 in tumor samples. This overexpression correlates with tumor progression and poor prognosis, providing statistical evidence for its involvement in the disease.",0,False,True
40cbef03-b5c3-4448-b00f-0ba2965dea9b,bix-37_q2,How does the adjusted p-value threshold of 0.05 affect the interpretation of ENO1's differential expression status?,,empty,ENO1's raw p-value of 0.031 passes the threshold but adjusted p-value of 0.226 does not,"<answer>An adjusted p-value threshold of 0.05 indicates that ENO1 is considered differentially expressed if its adjusted p-value is less than 0.05. This threshold helps control for false positives due to multiple testing, ensuring that there's a high confidence that ENO1's differential expression is not due to random chance.</answer>","An adjusted p-value threshold of 0.05 indicates that ENO1 is considered differentially expressed if its adjusted p-value is less than 0.05. This threshold helps control for false positives due to multiple testing, ensuring that there's a high confidence that ENO1's differential expression is not due to random chance.",0,False,True
40cbef03-b5c3-4448-b00f-0ba2965dea9b,bix-37_q3,"Based on the proteomics data, what is the fold change magnitude of ENO1 expression between tumor and normal samples?",,empty,4.81-fold increase in tumor,<answer> Data not provided </answer>,Data not provided,0,False,True
40cbef03-b5c3-4448-b00f-0ba2965dea9b,bix-37_q4,What is the base protein levels of ENO1 in normal samples according to the proteomic data?,,empty,"72,896,133 units",<answer> The specific base protein levels of ENO1 in normal samples according to proteomic data are not available in the information provided here. </answer>,The specific base protein levels of ENO1 in normal samples according to proteomic data are not available in the information provided here.,0,False,True
40cbef03-b5c3-4448-b00f-0ba2965dea9b,bix-37_q5,What is the adjusted p-value for ENO1's differential protein abundance/levels between tumor and normal samples?,,empty,0.226,<answer> The adjusted p-value for ENO1's differential protein abundance/levels between tumor and normal samples is not provided in the information available to me. </answer>,The adjusted p-value for ENO1's differential protein abundance/levels between tumor and normal samples is not provided in the information available to me.,0,False,True
40cbef03-b5c3-4448-b00f-0ba2965dea9b,bix-37_q6,What is the log2 fold change value for ENO1 in tumor samples compared to normal samples?,,empty,2.27,<answer> I don't have the specific data to calculate the log2 fold change value for ENO1 in tumor samples compared to normal samples. </answer>,I don't have the specific data to calculate the log2 fold change value for ENO1 in tumor samples compared to normal samples.,0,False,True
975f3e91-53b0-44b1-ac9f-20023d9c8cd0,bix-38_q1,What is the magnitude of difference in median tree length values between fungi and animals for single-copy orthologs?,,empty,2x larger in fungi,<answer> The magnitude of difference is not specified in the provided data. </answer>,The magnitude of difference is not specified in the provided data.,0,False,True
975f3e91-53b0-44b1-ac9f-20023d9c8cd0,bix-38_q2,What is the variance in tree length values among animal single-copy orthologs?,,empty,0.55,"<answer>The variance in tree length values among animal single-copy orthologs is not a fixed value and can vary depending on the dataset and methodology used for its calculation. Typically, tree lengths can show significant variance due to differences in evolutionary rates among lineages, gene conservation, and the scale of the dataset analyzed.</answer>","The variance in tree length values among animal single-copy orthologs is not a fixed value and can vary depending on the dataset and methodology used for its calculation. Typically, tree lengths can show significant variance due to differences in evolutionary rates among lineages, gene conservation, and the scale of the dataset analyzed.",0,False,True
975f3e91-53b0-44b1-ac9f-20023d9c8cd0,bix-38_q3,What percentage of fungal single-copy orthologs have tree lengths greater than 5.0?,,empty,5%,<answer>Data not available</answer>,Data not available,0,False,True
975f3e91-53b0-44b1-ac9f-20023d9c8cd0,bix-38_q4,What is the p-value for the difference in tree length distributions between yeasts and filamentous fungi?,,empty,0.01,<answer>Specific p-value data for the difference in tree length distributions between yeasts and filamentous fungi is not available. This is typically calculated through a statistical analysis tailored to the dataset in question.</answer>,Specific p-value data for the difference in tree length distributions between yeasts and filamentous fungi is not available. This is typically calculated through a statistical analysis tailored to the dataset in question.,0,False,True
975f3e91-53b0-44b1-ac9f-20023d9c8cd0,bix-38_q5,What percentage of orthologous genes in fungi show longer tree lengths compared to the mean tree length in animals?,,empty,94%,"<answer>Specific percentages can vary based on the dataset and methods used in the analysis, and there's no generally accepted universal percentage for this comparison. It is recommended to refer to specific academic literature or datasets for detailed results.</answer>","Specific percentages can vary based on the dataset and methods used in the analysis, and there's no generally accepted universal percentage for this comparison. It is recommended to refer to specific academic literature or datasets for detailed results.",0,False,True
975f3e91-53b0-44b1-ac9f-20023d9c8cd0,bix-38_q6,What is the median tree length ratio between fungal and animal orthologs?,,empty,2.1,<answer> The median tree length ratio between fungal and animal orthologs is approximately 0.629. </answer>,The median tree length ratio between fungal and animal orthologs is approximately 0.629.,0,False,True
28a5984e-9061-4d6f-99a1-40f8753bc9f4,bix-39_q1,What is the fold difference in median somatic CHIP variant frequency between BLM carriers and control parents?,,empty,Infinite (cannot be calculated),<answer>There is approximately a two-fold difference in median somatic CHIP variant frequency between BLM carriers and control parents.</answer>,There is approximately a two-fold difference in median somatic CHIP variant frequency between BLM carriers and control parents.,0,False,True
28a5984e-9061-4d6f-99a1-40f8753bc9f4,bix-39_q2,What is the interquartile range of somatic CHIP variant counts in BLM carriers?,,empty,2.5,<answer>Specific data on the interquartile range of somatic CHIP variant counts in BLM carriers is not provided here. Additional context or a specific dataset reference is required to answer this accurately.</answer>,Specific data on the interquartile range of somatic CHIP variant counts in BLM carriers is not provided here. Additional context or a specific dataset reference is required to answer this accurately.,0,False,True
28a5984e-9061-4d6f-99a1-40f8753bc9f4,bix-39_q3,How many CHIP variants are filtered out when applying the VAF < 0.3 threshold to the BLM carrier cohort?,,empty,28 variants,<answer> The specific number of CHIP variants filtered out in the BLM carrier cohort at a VAF < 0.3 is not provided here. </answer>,The specific number of CHIP variants filtered out in the BLM carrier cohort at a VAF < 0.3 is not provided here.,0,False,True
28a5984e-9061-4d6f-99a1-40f8753bc9f4,bix-39_q4,What percentage of initial CHIP variants are retained after filtering for exonic regions in the control parent cohort?,,empty,38%,<answer>45%</answer>,45%,0,False,True
d36654ed-2cd6-41c1-84f9-1a3a16be3de5,bix-40_q1,What percentage of BUSCO genes show zero variable sites in animal alignments compared to fungal alignments?,,empty,97% in animals vs 49% in fungi,<answer>Approximately 70% of BUSCO genes show zero variable sites in animal alignments compared to fungal alignments.</answer>,Approximately 70% of BUSCO genes show zero variable sites in animal alignments compared to fungal alignments.,0,False,True
d36654ed-2cd6-41c1-84f9-1a3a16be3de5,bix-40_q2,What is the median number of variable sites per BUSCO gene alignment in fungal species?,,empty,19 sites,<answer>Variable data not provided. Specific analyses required.</answer>,Variable data not provided. Specific analyses required.,0,False,True
d36654ed-2cd6-41c1-84f9-1a3a16be3de5,bix-40_q3,What percentage of fungal BUSCO genes show greater than 3.8% variable sites in their alignments?,,empty,50%,<answer>8.7%</answer>,8.7%,0,False,True
d36654ed-2cd6-41c1-84f9-1a3a16be3de5,bix-40_q4,What is the BUSCO gene ID showing the highest percentage of variable sites among all animal alignments?,,empty,1620056at2759,<answer>BUSCO gene IDs and their percentage of variable sites are not available in this format. This information typically requires specific computational analysis of genomic data.</answer>,BUSCO gene IDs and their percentage of variable sites are not available in this format. This information typically requires specific computational analysis of genomic data.,0,False,True
d36654ed-2cd6-41c1-84f9-1a3a16be3de5,bix-40_q5,What percentage of animal orthologous genes contain zero variable sites?,,empty,90%,<answer>Approximately 13% of animal orthologous genes contain zero variable sites.</answer>,Approximately 13% of animal orthologous genes contain zero variable sites.,0,False,True
d36654ed-2cd6-41c1-84f9-1a3a16be3de5,bix-40_q6,What is the absolute difference in variable sites between animals and fungi for ortholog 1014314at2759?,,empty,9 sites,"```xml
<answer>12</answer>
```",12,0,False,True
8b462015-86ab-434f-29e1-04dda1588031,bix-41_q1,"According to Dunnett's test comparing co-culture groups to the wild-type, at the significance threshold of 0.05, which of the following ratios of ΔrhlI:ΔlasI co-culture failed to demonstrate statistical equivalence to wild-type in both area and circularity measurements? (ΔrhlI is Strain 287; ΔlasI is Strain 98;  wild-type is Strain 1)",,empty,10:1,<answer> The specific ratios of ΔrhlI:ΔlasI not demonstrating statistical equivalence to wild-type in both area and circularity measurements at a 0.05 significance threshold are not provided as there is no data given in the question. </answer>,The specific ratios of ΔrhlI:ΔlasI not demonstrating statistical equivalence to wild-type in both area and circularity measurements at a 0.05 significance threshold are not provided as there is no data given in the question.,0,False,True
8b462015-86ab-434f-29e1-04dda1588031,bix-41_q2,What is the p-value threshold that defines statistical significance for the difference in colony area between co-culture conditions and wild-type in the analysis?,,empty,0.05,<answer>0.05</answer>,0.05,1,True,True
8b462015-86ab-434f-29e1-04dda1588031,bix-41_q3,What is the mean difference in circularity between the ΔlasI mutant (Strain 98) and the wild-type (Strain 1)?,,empty,0.43,"<answer> The paper or dataset needed to determine the mean difference in circularity between the ΔlasI mutant (Strain 98) and the wild-type (Strain 1) is not provided. Therefore, I cannot output the answer. </answer>","The paper or dataset needed to determine the mean difference in circularity between the ΔlasI mutant (Strain 98) and the wild-type (Strain 1) is not provided. Therefore, I cannot output the answer.",0,False,True
8b462015-86ab-434f-29e1-04dda1588031,bix-41_q4,How many different co-culture ratios demonstrate significant differences from wild-type (Strain 1) in both area and circularity measurements?,,empty,4,<answer> The question lacks specific data about the co-culture ratios and their measurements needed to provide an accurate answer. </answer>,The question lacks specific data about the co-culture ratios and their measurements needed to provide an accurate answer.,0,False,True
8b462015-86ab-434f-29e1-04dda1588031,bix-41_q5,At what ratio of ΔrhlI:ΔlasI does swarming behavior most closely match wildtype phenotype based on the means for both area and circularity measurements?,,empty,5:1,<answer>1:1</answer>,1:1,0,False,True
27821d45-94e6-4f4e-a914-e66ffaefdd3f,bix-42_q1,How many patients in the provided dataset can be used for survival prediction using integrated RNA expression and DNA methylation data?,,empty,267,<answer> The number of patients is not specified in the provided context. </answer>,The number of patients is not specified in the provided context.,0,False,True
27821d45-94e6-4f4e-a914-e66ffaefdd3f,bix-42_q2,What is the skewness of the distribution of RNA expression data?,,empty,Highly left-skewed,"<answer>The skewness of RNA expression data distributions can vary, but they are often right-skewed (positively skewed) due to a small number of genes being highly expressed.</answer>","The skewness of RNA expression data distributions can vary, but they are often right-skewed (positively skewed) due to a small number of genes being highly expressed.",0,False,True
27821d45-94e6-4f4e-a914-e66ffaefdd3f,bix-42_q3,"Which dataset (Methylation or Expression), or their integration, demonstrates the strongest predictive power for patient survival among those provided?",,empty,DNA Methylation,"```xml
<answer>Integration of Methylation and Expression datasets</answer>
```",Integration of Methylation and Expression datasets,0,False,True
15ff11e5-2db1-45b6-b3a3-46bc2a74b821,bix-43_q1,"When comparing CBD/cisplatin combination treatment to DMSO control, which cellular process shows the strongest statistical significance in a GO Biological Process enrichment analysis?",,empty,Negative regulation of epithelial cell proliferation,<answer>Apoptotic process</answer>,Apoptotic process,0,False,True
15ff11e5-2db1-45b6-b3a3-46bc2a74b821,bix-43_q2,What is the odds ratio for p53-mediated cell cycle gene regulation when performing a Reactome pathway analysis of CBD/cisplatin combination treatment?,,empty,6.02,"<answer> The odds ratio for p53-mediated cell cycle gene regulation in the context of Reactome pathway analysis of CBD/cisplatin combination treatment is not specified here; typically, the exact value would depend on the specific data from the analysis conducted. </answer>","The odds ratio for p53-mediated cell cycle gene regulation in the context of Reactome pathway analysis of CBD/cisplatin combination treatment is not specified here; typically, the exact value would depend on the specific data from the analysis conducted.",0,False,True
15ff11e5-2db1-45b6-b3a3-46bc2a74b821,bix-43_q3,"How many genes show significant differential expression (padj < 0.05, |log2FoldChange| > 0.5) in the CBD/cisplatin combination treatment compared to DMSO control?",,empty,679,"```xml
<answer> 42 </answer>
```",42,0,False,True
15ff11e5-2db1-45b6-b3a3-46bc2a74b821,bix-43_q4,What proportion of regulated genes in the CBD/cisplatin treatment contribute to the enrichment of p53-regulated cell cycle process identified in the Reactome pathway analysis?,,empty,8/49,<answer> The specific proportion of regulated genes in the CBD/cisplatin treatment contributing to the enrichment of p53-regulated cell cycle process is not available in the provided data. </answer>,The specific proportion of regulated genes in the CBD/cisplatin treatment contributing to the enrichment of p53-regulated cell cycle process is not available in the provided data.,0,False,True
15ff11e5-2db1-45b6-b3a3-46bc2a74b821,bix-43_q5,What is the primary cellular mechanism enriched in the CBD/cisplatin combination treatment according to pathway analysis?,,empty,p53-mediated cell cycle regulation,<answer>The primary cellular mechanism enriched in the CBD/cisplatin combination treatment is the modulation of the apoptotic pathway.</answer>,The primary cellular mechanism enriched in the CBD/cisplatin combination treatment is the modulation of the apoptotic pathway.,0,False,True
15ff11e5-2db1-45b6-b3a3-46bc2a74b821,bix-43_q6,What is the adjusted p-value for enrichment of cytoskeleton organization processes in the enrichment analysis?,,empty,0.103838,<answer> The adjusted p-value for enrichment of cytoskeleton organization processes is not provided in the question. Please provide details of the analysis results. </answer>,The adjusted p-value for enrichment of cytoskeleton organization processes is not provided in the question. Please provide details of the analysis results.,0,False,True
15ff11e5-2db1-45b6-b3a3-46bc2a74b821,bix-43_q7,"How many differentially regulated genes contribute to the the p53-mediated cell cycle regulation pathway enrichment?
",,empty,8,"```xml
<answer>14</answer>
```",14,0,False,True
2ed9023e-75d7-40fe-a425-b6b84ac8329c,bix-44_q1,What is the median compositional bias value for fungal protein sequences in the analyzed BUSCO gene alignments?,,empty,0.0,<answer> The median compositional bias value for fungal protein sequences in the analyzed BUSCO gene alignments is not directly available as a standard value. It would typically require specific analysis of the dataset in question. </answer>,The median compositional bias value for fungal protein sequences in the analyzed BUSCO gene alignments is not directly available as a standard value. It would typically require specific analysis of the dataset in question.,0,False,True
2ed9023e-75d7-40fe-a425-b6b84ac8329c,bix-44_q2,What percentage of alignment sites in animal BUSCO genes show compositional bias values above 0.4?,,empty,8%,<answer>Approximately 1% of alignment sites in animal BUSCO genes show compositional bias values above 0.4.</answer>,Approximately 1% of alignment sites in animal BUSCO genes show compositional bias values above 0.4.,0,False,True
2ed9023e-75d7-40fe-a425-b6b84ac8329c,bix-44_q3,How many individual alignment sites in fungal BUSCO genes demonstrate compositional bias values exceeding 0.75?,,empty,"7,615","```xml
<answer> The specific number of individual alignment sites in fungal BUSCO genes exceeding a compositional bias of 0.75 is not provided in my data up to October 2023. </answer>
```",The specific number of individual alignment sites in fungal BUSCO genes exceeding a compositional bias of 0.75 is not provided in my data up to October 2023.,0,False,True
ebc7c8a6-ba34-46db-bf8c-b3e310434ba9,bix-45_q1,"Based on the average relative compositional variability (RCV) across orthologous genes, what is the relationship between animals and fungi compositional biases?",,empty,"Animals have a lower average RCV value compared to fungi, indicating lower compositional biases.","<answer>The relationship between animals and fungi compositional biases shows that both exhibit a high degree of compositional variability across orthologous genes, indicating that they possess distinct compositional biases despite sharing a common ancestor.</answer>","The relationship between animals and fungi compositional biases shows that both exhibit a high degree of compositional variability across orthologous genes, indicating that they possess distinct compositional biases despite sharing a common ancestor.",0,False,True
ebc7c8a6-ba34-46db-bf8c-b3e310434ba9,bix-45_q2,What is the median RCV score for fungal orthologs in the dataset?,,empty,0.22,"```xml
<answer>Insufficient information provided to determine the median RCV score for fungal orthologs.</answer>
```",Insufficient information provided to determine the median RCV score for fungal orthologs.,0,False,True
ebc7c8a6-ba34-46db-bf8c-b3e310434ba9,bix-45_q3,What percentage of orthologous genes show an RCV score above 0.25 in the animal dataset?,,empty,7%,<answer> The specific percentage of orthologous genes with an RCV score above 0.25 in the animal dataset is not provided in the given context. </answer>,The specific percentage of orthologous genes with an RCV score above 0.25 in the animal dataset is not provided in the given context.,0,False,True
ebc7c8a6-ba34-46db-bf8c-b3e310434ba9,bix-45_q4,What is the effect size (calculated as difference in medians divided by pooled standard deviation) of the RCV score difference between animals and fungi?,,empty,-0.62,<answer> The effect size cannot be determined without specific numerical values for the medians and pooled standard deviation of the RCV scores for animals and fungi. </answer>,The effect size cannot be determined without specific numerical values for the medians and pooled standard deviation of the RCV scores for animals and fungi.,0,False,True
ebc7c8a6-ba34-46db-bf8c-b3e310434ba9,bix-45_q5,What is the median RCV value difference between animals and fungi?,,empty,0.12,"```xml
<answer>0.2</answer>
```",0.2,0,False,True
ebc7c8a6-ba34-46db-bf8c-b3e310434ba9,bix-45_q6,What is the 75th percentile RCV value for fungal orthologous genes?,,empty,0.27,<answer>Data not provided to determine the 75th percentile RCV value for fungal orthologous genes.</answer>,Data not provided to determine the 75th percentile RCV value for fungal orthologous genes.,0,False,True
d37acffb-d802-4ce0-8caa-66f50667367a,bix-46_q1,What expression pattern in the mexGHI operon genes would suggest they were promising candidates for mediating division of labor between ΔrhlI (strain #97) and ΔlasI (strain #98) strains?,,empty,Strong downregulation in ΔrhlI (strain #97) and no change/upregulaton in ΔlasI (strain #98),"<answer>An expression pattern where mexGHI operon genes are upregulated in ΔrhlI (strain #97) but downregulated or unchanged in ΔlasI (strain #98) would suggest they are promising candidates for mediating division of labor, indicating complementary roles or compensatory mechanisms in these strains.</answer>","An expression pattern where mexGHI operon genes are upregulated in ΔrhlI (strain #97) but downregulated or unchanged in ΔlasI (strain #98) would suggest they are promising candidates for mediating division of labor, indicating complementary roles or compensatory mechanisms in these strains.",0,False,True
d37acffb-d802-4ce0-8caa-66f50667367a,bix-46_q2,What is the log2 fold change value for mexG expression in ΔrhlI (strain #97) compared to wt (strain #1)?,,empty,-4.01,<answer> The specific log2 fold change value for mexG expression in ΔrhlI (strain #97) compared to wt (strain #1) is not provided in the data I have. </answer>,The specific log2 fold change value for mexG expression in ΔrhlI (strain #97) compared to wt (strain #1) is not provided in the data I have.,0,False,True
d37acffb-d802-4ce0-8caa-66f50667367a,bix-46_q3,How many genes with a log2 fold ratio lower than -4 show significant differential expression (padj < 0.05) exclusively in ΔlasI (strain #98) but not in ΔrhlI (strain #97)?,,empty,8,"```xml
<answer> 15 </answer>
```",15,0,False,True
d37acffb-d802-4ce0-8caa-66f50667367a,bix-46_q4,"Based on differential expression analysis of ΔrhlI (strain #97) vs. wt (strain #1), which metabolic pathway is most strongly down regulated in ΔrhlI (strain #97)?",,empty,Phenazine biosynthesis,<answer>Rhamnolipid biosynthesis pathway</answer>,Rhamnolipid biosynthesis pathway,0,False,True
d37acffb-d802-4ce0-8caa-66f50667367a,bix-46_q5,"How many genes show significant downregulation, at a log2 fold change lower than -5, exclusively in ΔrhlI (strain #97)?",,empty,8,"```xml
<answer> Your answer </answer>
```",Your answer,0,False,True
d37acffb-d802-4ce0-8caa-66f50667367a,bix-46_q6,What is the log2 fold change value for the phenazine pathway gene PA14_35160 in the ΔrhlI mutant?,,empty,-4.10,<answer>-1.75</answer>,-1.75,0,False,True
4a336d0c-3d6b-440a-bfb0-437b26a00af3,bix-47_q1,How does the distribution of somatic CHIP variants change across individuals with or without mutations in the BLM gene?,,empty,It doesn't change significantly,"<answer>In individuals with mutations in the BLM gene, there is typically an increased burden and altered distribution of somatic CHIP variants compared to individuals without BLM mutations. This is due to BLM's role in DNA repair; mutations can lead to genomic instability, affecting the distribution of somatic variants.</answer>","In individuals with mutations in the BLM gene, there is typically an increased burden and altered distribution of somatic CHIP variants compared to individuals without BLM mutations. This is due to BLM's role in DNA repair; mutations can lead to genomic instability, affecting the distribution of somatic variants.",0,False,True
4a336d0c-3d6b-440a-bfb0-437b26a00af3,bix-47_q2,What is the name of the gene showing the highest number of CHIP variants across all samples?,,empty,P184,<answer>DNMT3A</answer>,DNMT3A,0,False,True
4a336d0c-3d6b-440a-bfb0-437b26a00af3,bix-47_q3,"In the hierarchical clustering analysis, what is the cophenetic correlation coefficient between the gene clustering and the original distance matrix?",,empty,0.91,"<answer> The cophenetic correlation coefficient is a measure used to evaluate how faithfully a dendrogram preserves the pairwise distances between the original data points. However, without specific data or results from an analysis, an exact value cannot be provided. Normally, a high cophenetic correlation coefficient indicates a good fit of the clustering to the data. </answer>","The cophenetic correlation coefficient is a measure used to evaluate how faithfully a dendrogram preserves the pairwise distances between the original data points. However, without specific data or results from an analysis, an exact value cannot be provided. Normally, a high cophenetic correlation coefficient indicates a good fit of the clustering to the data.",0,False,True
4a336d0c-3d6b-440a-bfb0-437b26a00af3,bix-47_q4,What is the ratio of missense to nonsense variants in CHIP genes among control children samples?,,empty,3.4:1,<answer>Data specific to the ratio of missense to nonsense variants in CHIP genes among control children samples is not available.</answer>,Data specific to the ratio of missense to nonsense variants in CHIP genes among control children samples is not available.,0,False,True
a45810bb-beee-466a-b31f-ba60268afa53,bix-48_q1,"Using the average mean pairwise identity values from single-copy orthologous genes, what is the statistical relationship between evolutionary rates in animals and fungi?",,empty,Animals evolve 1.5x faster than fungi with p < 0.0001,"<answer>The statistical relationship between evolutionary rates in animals and fungi, as determined by average mean pairwise identity values from single-copy orthologous genes, typically shows that fungi generally have higher evolutionary rates compared to animals. This is attributed to the greater genetic and phenotypic diversity observed in fungi.</answer>","The statistical relationship between evolutionary rates in animals and fungi, as determined by average mean pairwise identity values from single-copy orthologous genes, typically shows that fungi generally have higher evolutionary rates compared to animals. This is attributed to the greater genetic and phenotypic diversity observed in fungi.",0,False,True
a45810bb-beee-466a-b31f-ba60268afa53,bix-48_q2,What is the distribution pattern of median evolutionary rates across single-copy orthologous genes in animals?,,empty,Right-skewed distribution with median 0.46 pairwise identity,"<answer>The distribution pattern of median evolutionary rates across single-copy orthologous genes in animals typically follows a right-skewed distribution, indicating that while most genes evolve at comparable, slower rates, a smaller proportion evolves much more rapidly.</answer>","The distribution pattern of median evolutionary rates across single-copy orthologous genes in animals typically follows a right-skewed distribution, indicating that while most genes evolve at comparable, slower rates, a smaller proportion evolves much more rapidly.",1,True,True
a45810bb-beee-466a-b31f-ba60268afa53,bix-48_q3,What is the ratio of standard deviation medians in evolutionary rates between animals and fungi?,,empty,Animals show 2.5x higher standard deviation than fungi,<answer>1.44</answer>,1.44,0,False,True
a45810bb-beee-466a-b31f-ba60268afa53,bix-48_q4,What proportion of single-copy orthologous genes show faster median evolutionary rates in animals compared to the median fungi evolutionary rate?,,empty,72% of genes have a higher median evolutionary rate in animals,"<answer>Without specific data or studies referenced, it's not possible to provide an exact proportion. However, generally, evolutionary rates can vary significantly across different gene families and are context-dependent. Detailed phylogenetic analysis studies are required to provide such specific insights.</answer>","Without specific data or studies referenced, it's not possible to provide an exact proportion. However, generally, evolutionary rates can vary significantly across different gene families and are context-dependent. Detailed phylogenetic analysis studies are required to provide such specific insights.",0,False,True
a45810bb-beee-466a-b31f-ba60268afa53,bix-48_q5,What is the average mean evolutionary rate for fungal species based on pairwise sequence identities?,,empty,0.39,"<answer>Due to the complexity and variability in fungal species, specific average mean evolutionary rates based on pairwise sequence identities can vary widely. However, in general, fungal species can have evolutionary rates ranging from 1x10^-9 to 5x10^-8 substitutions per site per year. Accurate rates require specific phylogenetic and genomic analysis.</answer>","Due to the complexity and variability in fungal species, specific average mean evolutionary rates based on pairwise sequence identities can vary widely. However, in general, fungal species can have evolutionary rates ranging from 1x10^-9 to 5x10^-8 substitutions per site per year. Accurate rates require specific phylogenetic and genomic analysis.",0,False,True
a45810bb-beee-466a-b31f-ba60268afa53,bix-48_q6,What is the difference in average median evolutionary rates between animals and fungi?,,empty,0.09,"<answer>Animals generally have a higher average median evolutionary rate compared to fungi. This is often due to differences in life history traits, ecological roles, and population sizes which can impact evolution rates.</answer>","Animals generally have a higher average median evolutionary rate compared to fungi. This is often due to differences in life history traits, ecological roles, and population sizes which can impact evolution rates.",0,False,True
a45810bb-beee-466a-b31f-ba60268afa53,bix-48_q7,What is the average standard deviation of evolutionary rates among fungal species?,,empty,0.09,"<answer>Data on the average standard deviation of evolutionary rates among fungal species can vary widely depending on the specific genes and methods used in the studies, and there is not a universally accepted single value. Therefore, it is challenging to provide a concise average without specific context or recent meta-analyses.</answer>","Data on the average standard deviation of evolutionary rates among fungal species can vary widely depending on the specific genes and methods used in the studies, and there is not a universally accepted single value. Therefore, it is challenging to provide a concise average without specific context or recent meta-analyses.",0,False,True
4ef3fcd8-1c35-466f-9d93-49b92f4ea760,bix-49_q1,What is the ratio of blood-specific DEGs to fibroblast-specific DEGs in the ASXL1 mutation analysis?,,empty,12:1,"```xml
<answer>3:1</answer>
```",3:1,0,False,True
4ef3fcd8-1c35-466f-9d93-49b92f4ea760,bix-49_q2,"What is the maximum log2 fold change observed among statistically significant DEGs in the blood RNA-seq analysis, after adjusting the differential gene expression model with the available metadata?",,empty,4.21,"<answer> The maximum log2 fold change among statistically significant DEGs in the blood RNA-seq analysis, after model adjustment, is not available as it is specific to the analysis dataset which I do not have access to. </answer>","The maximum log2 fold change among statistically significant DEGs in the blood RNA-seq analysis, after model adjustment, is not available as it is specific to the analysis dataset which I do not have access to.",0,False,True
4ef3fcd8-1c35-466f-9d93-49b92f4ea760,bix-49_q3,What is the adjusted p-value of GRIK5 when performing differential expression analysis on the blood RNA-seq dataset?,,empty,8.93e-10,"```xml
<answer>Data needed to determine the adjusted p-value of GRIK5 is not provided. Please provide the relevant dataset and analysis details.</answer>
```",Data needed to determine the adjusted p-value of GRIK5 is not provided. Please provide the relevant dataset and analysis details.,0,False,True
4ef3fcd8-1c35-466f-9d93-49b92f4ea760,bix-49_q4,How many genes show a positive log2 fold change (upregulation) among the significant (padj < 0.05) DEGs in the blood RNA-seq analysis?,,empty,833,"```xml
<answer> Your answer </answer>
```",Your answer,0,False,True
4ef3fcd8-1c35-466f-9d93-49b92f4ea760,bix-49_q5,What is the total number of significantly dysregulated genes (padj < 0.05) identified in the blood RNA-seq analysis?,,empty,1106,<answer> The total number of significantly dysregulated genes (padj < 0.05) identified in the blood RNA-seq analysis is not provided in the input. </answer>,The total number of significantly dysregulated genes (padj < 0.05) identified in the blood RNA-seq analysis is not provided in the input.,0,False,True
4ef3fcd8-1c35-466f-9d93-49b92f4ea760,bix-49_q6,What is the log2 fold change value for the GRIK5 gene in the differential expression analysis?,,empty,4.089,<answer> The log2 fold change value for the GRIK5 gene is not specified here. Please refer to your differential expression analysis results. </answer>,The log2 fold change value for the GRIK5 gene is not specified here. Please refer to your differential expression analysis results.,0,False,True
d49cde68-cc3a-479d-88cb-11302207ac3c,bix-50_q1,"What is the median evolutionary rate per site, as measured by compositional bias, in fungal proteomes compared to animal proteomes?",,empty,0.36 in fungi vs 0.0 in animals,"<answer>Fungal proteomes generally have a higher median evolutionary rate per site compared to animal proteomes, attributed to differences in compositional bias.</answer>","Fungal proteomes generally have a higher median evolutionary rate per site compared to animal proteomes, attributed to differences in compositional bias.",0,False,True
d49cde68-cc3a-479d-88cb-11302207ac3c,bix-50_q2,What percentage of sites in fungal proteomes show evolutionary rates above 0.4?,,empty,35%,<answer>20.5%</answer>,20.5%,0,False,True
d49cde68-cc3a-479d-88cb-11302207ac3c,bix-50_q3,How many rapidly evolving sites (compositional bias > 0.5) are present in animal proteomes?,,empty,"5,000 sites",<answer>Information on the specific number of rapidly evolving sites (compositional bias > 0.5) in animal proteomes is not readily available in my training data. This requires detailed bioinformatics analysis of proteomic datasets.</answer>,Information on the specific number of rapidly evolving sites (compositional bias > 0.5) in animal proteomes is not readily available in my training data. This requires detailed bioinformatics analysis of proteomic datasets.,0,False,True
d49cde68-cc3a-479d-88cb-11302207ac3c,bix-50_q4,What is the Mann-Whitney U test statistic when comparing evolutionary rates between animal and fungal proteomes?,,empty,"7,492,955,849.5","<answer>To determine the Mann-Whitney U test statistic when comparing evolutionary rates between animal and fungal proteomes, one would need specific data from a study or analysis. Without the data, the U statistic cannot be calculated or provided here.</answer>","To determine the Mann-Whitney U test statistic when comparing evolutionary rates between animal and fungal proteomes, one would need specific data from a study or analysis. Without the data, the U statistic cannot be calculated or provided here.",0,False,True
93f63fb8-b56c-4ad1-8d3b-d651e2107423,bix-51_q1,"Using a logistic regression model, with age, BMI and gender as predictors (combined model) what is the predicted probability of achieving remission (CR/PR) with camrelizumab treatment in patients aged 65-75?",,empty,0.25-0.35,"<answer> The predicted probability depends on the specific coefficients determined by the logistic regression model fitted on the dataset. Without access to the exact model parameters, it's not possible to provide an exact probability.</answer>","The predicted probability depends on the specific coefficients determined by the logistic regression model fitted on the dataset. Without access to the exact model parameters, it's not possible to provide an exact probability.",0,False,True
93f63fb8-b56c-4ad1-8d3b-d651e2107423,bix-51_q2,What is the AIC value for the logistic regression model containing only BMI as a predictor?,,empty,111.81,"<answer> The AIC value for the logistic regression model containing only BMI as a predictor is not directly available as it requires specific data input and model fitting process. To obtain the AIC value, you need to perform logistic regression analysis using statistical software on your dataset. </answer>","The AIC value for the logistic regression model containing only BMI as a predictor is not directly available as it requires specific data input and model fitting process. To obtain the AIC value, you need to perform logistic regression analysis using statistical software on your dataset.",0,False,True
93f63fb8-b56c-4ad1-8d3b-d651e2107423,bix-51_q3,"What is the p-value for the effect of age in the logistic regression model that uses age, BMI, and gender as predictors (combined model)?",,empty,0.0025,<answer>Insufficient data to calculate the p-value for age in the specified logistic regression model.</answer>,Insufficient data to calculate the p-value for age in the specified logistic regression model.,0,False,True
93f63fb8-b56c-4ad1-8d3b-d651e2107423,bix-51_q4,"What is the change in log-odds of remission for each year increase in patient age, when using the combined model?",,empty,-0.07951,"<answer> The change in log-odds of remission for each year increase in patient age, when using the combined model, is not specified in the provided context. </answer>","The change in log-odds of remission for each year increase in patient age, when using the combined model, is not specified in the provided context.",0,False,True
93f63fb8-b56c-4ad1-8d3b-d651e2107423,bix-51_q5,What is the p-value for BMI as an individual predictor of camrelizumab treatment response in a simple logistic regression model?,,empty,0.0865,<answer> The p-value for BMI as an individual predictor of camrelizumab treatment response in a simple logistic regression model is not provided in the data I was trained on. </answer>,The p-value for BMI as an individual predictor of camrelizumab treatment response in a simple logistic regression model is not provided in the data I was trained on.,0,False,True
93f63fb8-b56c-4ad1-8d3b-d651e2107423,bix-51_q6,What is the AIC value for the logistic regression model using only age as a predictor of camrelizumab treatment response?,,empty,104.14,"<answer> The AIC value must be calculated using the specific dataset and logistic regression model you have. Without executing the model on your data, it is impossible to provide the AIC. </answer>","The AIC value must be calculated using the specific dataset and logistic regression model you have. Without executing the model on your data, it is impossible to provide the AIC.",0,False,True
4dceea58-7d66-4576-bfc6-88c026d5b7a9,bix-52_q1,What is the ratio of filtered (>90% or <10% methylation) age-related CpG density between chromosome W and chromosome 1 in the Zebra Finch genome?,,empty,1.5,"<answer>There is no specific publicly available data on the filtered age-related CpG density ratios between chromosome W and chromosome 1 in the Zebra Finch genome as of the current knowledge. For accurate information, a specialized genomic study or analysis of the Zebra Finch genome would be required.</answer>","There is no specific publicly available data on the filtered age-related CpG density ratios between chromosome W and chromosome 1 in the Zebra Finch genome as of the current knowledge. For accurate information, a specialized genomic study or analysis of the Zebra Finch genome would be required.",0,False,True
4dceea58-7d66-4576-bfc6-88c026d5b7a9,bix-52_q2,What is the genome-wide average density of age-related CpGs per base pair in the Jackdaw genome?,,empty,6.0 x 10^-8,<answer>There is no specific data available on the genome-wide average density of age-related CpGs per base pair in the Jackdaw genome.</answer>,There is no specific data available on the genome-wide average density of age-related CpGs per base pair in the Jackdaw genome.,0,False,True
4dceea58-7d66-4576-bfc6-88c026d5b7a9,bix-52_q3,What is the chi-square statistic for the distribution of filtered age-related CpG sites (>90% or <10% methylation) across chromosomes in the Zebra Finch genome?,,empty,458.27,<answer> The exact chi-square statistic for the distribution of filtered age-related CpG sites across chromosomes in the Zebra Finch genome is not specified in the data I have. You would need to refer to the specific scientific study or dataset that analyzed this information to obtain the precise value. </answer>,The exact chi-square statistic for the distribution of filtered age-related CpG sites across chromosomes in the Zebra Finch genome is not specified in the data I have. You would need to refer to the specific scientific study or dataset that analyzed this information to obtain the precise value.,0,False,True
4dceea58-7d66-4576-bfc6-88c026d5b7a9,bix-52_q4,What is the difference in proportion of age-related CpGs found on chromosome 2 between Zebra Finch and Jackdaw?,,empty,0.12,"<answer>Due to the specificity of the question and the lack of publicly available detailed genomic data comparing age-related CpGs on chromosome 2 between Zebra Finch and Jackdaw, I am unable to provide a direct numerical answer. Further studies or datasets would be required to accurately determine this proportion difference.</answer>","Due to the specificity of the question and the lack of publicly available detailed genomic data comparing age-related CpGs on chromosome 2 between Zebra Finch and Jackdaw, I am unable to provide a direct numerical answer. Further studies or datasets would be required to accurately determine this proportion difference.",0,False,True
4dceea58-7d66-4576-bfc6-88c026d5b7a9,bix-52_q5,What is the density of filtered age-related CpG sites (>90% or <10% methylation) on chromosome Z in the Zebra Finch genome?,,empty,0.000000639 CpGs per base,"<answer>The specific density of filtered age-related CpG sites on chromosome Z in the Zebra Finch genome is not readily available in my current dataset. For precise details, a study focused on this specific analysis would be needed.</answer>","The specific density of filtered age-related CpG sites on chromosome Z in the Zebra Finch genome is not readily available in my current dataset. For precise details, a study focused on this specific analysis would be needed.",0,False,True
4dceea58-7d66-4576-bfc6-88c026d5b7a9,bix-52_q6,Which chromosome in the Jackdaw genome shows the highest density of age-related CpG sites?,,empty,Chromosome W,<answer>Chromosome 2</answer>,Chromosome 2,0,False,True
308d53bf-1513-4a09-913b-3a1112f94e7b,bix-53_q1,What is the relative enrichment ranking of oxidative stress-related pathways compared to inflammatory response pathways in the WikiPathways analysis of UBEM2 KD effects?,,empty,Oxidative stress pathways appear only after the top 10 most enriched pathways,<answer> The information required to provide the relative enrichment ranking of oxidative stress-related pathways compared to inflammatory response pathways in the WikiPathways analysis of UBEM2 KD effects is not available. </answer>,The information required to provide the relative enrichment ranking of oxidative stress-related pathways compared to inflammatory response pathways in the WikiPathways analysis of UBEM2 KD effects is not available.,0,False,True
308d53bf-1513-4a09-913b-3a1112f94e7b,bix-53_q2,How does the removal of the third replicate from both conditions affect the number of significantly differentially expressed genes identified?,,empty,Increases from 1416 to 1942 significant genes,"<answer>The removal of the third replicate from both conditions may reduce the statistical power of the analysis, leading to fewer significantly differentially expressed genes being identified due to increased variability and reduced confidence in estimating expression differences.</answer>","The removal of the third replicate from both conditions may reduce the statistical power of the analysis, leading to fewer significantly differentially expressed genes being identified due to increased variability and reduced confidence in estimating expression differences.",0,False,True
308d53bf-1513-4a09-913b-3a1112f94e7b,bix-53_q3,What is the number of DGEs which contribute to the glutathione metabolism pathway enrichment in the UBEM2 KD condition?,,empty,22/64 genes,"```xml
<answer>15</answer>
```",15,0,False,True
308d53bf-1513-4a09-913b-3a1112f94e7b,bix-53_q4,What is the adjusted p-value for the enrichment of the oxidative stress pathway in the WikiPathways analysis?,,empty,3.011783e-06,"<answer> The adjusted p-value for the oxidative stress pathway in the WikiPathways analysis is not provided, as it requires specific dataset analysis which isn't available here. </answer>","The adjusted p-value for the oxidative stress pathway in the WikiPathways analysis is not provided, as it requires specific dataset analysis which isn't available here.",0,False,True
308d53bf-1513-4a09-913b-3a1112f94e7b,bix-53_q5,What is the proportion of oxidative stress-related pathways among the top 20 enriched pathways in the WikiPathways analysis?,,empty,2 out of 20 pathways,<answer>There is no specific number generally applicable; it depends on the specific analysis and dataset in question. Please provide the analysis results for accurate interpretation.</answer>,There is no specific number generally applicable; it depends on the specific analysis and dataset in question. Please provide the analysis results for accurate interpretation.,0,False,True
308d53bf-1513-4a09-913b-3a1112f94e7b,bix-53_q6,What is the most significantly enriched pathway in the KEGG analysis in the UBEM2 KD model?,,empty,Leishmaniasis,"<answer>Without access to specific research data or studies regarding the UBEM2 KD model, I cannot provide an answer to the most significantly enriched pathway in the KEGG analysis. This information would typically be found in a specific scientific paper or dataset.</answer>","Without access to specific research data or studies regarding the UBEM2 KD model, I cannot provide an answer to the most significantly enriched pathway in the KEGG analysis. This information would typically be found in a specific scientific paper or dataset.",0,False,True
308d53bf-1513-4a09-913b-3a1112f94e7b,bix-53_q7,How does sample clustering in the PCA plot change after removing the third replicate from both conditions?,,empty,Only KD samples show remaining variation,"<answer>Removing the third replicate from both conditions in a PCA plot may lead to a change in the clustering of the samples as it alters the dataset used for Principal Component Analysis. The overall variance captured by the principal components might shift, potentially resulting in a clearer separation or different grouping of the remaining samples, as outliers or less consistent data points are removed. This could enhance or diminish the observable patterns depending on the characteristics of the third replicates.</answer>","Removing the third replicate from both conditions in a PCA plot may lead to a change in the clustering of the samples as it alters the dataset used for Principal Component Analysis. The overall variance captured by the principal components might shift, potentially resulting in a clearer separation or different grouping of the remaining samples, as outliers or less consistent data points are removed. This could enhance or diminish the observable patterns depending on the characteristics of the third replicates.",0,False,True
9e52daf6-ca58-43e8-e732-fbac3459d295,bix-54_q1,At what frequency ratio of ΔrhlI to total population is the maximum swarming area predicted?,,empty,0.907,<answer>0.0025</answer>,0.0025,0,False,True
9e52daf6-ca58-43e8-e732-fbac3459d295,bix-54_q2,What is the R-squared value for the cubic model fit to the swarming area data?,,empty,0.5876,<answer> The R-squared value for the cubic model fit to the swarming area data is not provided. </answer>,The R-squared value for the cubic model fit to the swarming area data is not provided.,0,False,True
9e52daf6-ca58-43e8-e732-fbac3459d295,bix-54_q3,What is the lower bound of the 95% confidence interval for the peak swarming area according to the spline model?,,empty,"157,912 mm²","<answer> The specific value for the lower bound of the 95% confidence interval for the peak swarming area according to the spline model needs to be provided by the source dataset or study, as it is not available in the information I was trained on. </answer>","The specific value for the lower bound of the 95% confidence interval for the peak swarming area according to the spline model needs to be provided by the source dataset or study, as it is not available in the information I was trained on.",0,False,True
9e52daf6-ca58-43e8-e732-fbac3459d295,bix-54_q4,What is the p-value for the F-statistic in the spline model analysis of swarming area?,,empty,1.131e-11,"<answer>To accurately answer this, specific details from the spline model analysis data are required, which are not provided in the question. Please consult the results of your analysis where the p-value is directly given.</answer>","To accurately answer this, specific details from the spline model analysis data are required, which are not provided in the question. Please consult the results of your analysis where the p-value is directly given.",0,False,True
9e52daf6-ca58-43e8-e732-fbac3459d295,bix-54_q5,At what frequency ratio of ΔrhlI:ΔlasI does the bacterial colony achieve its maximum area?,,empty,0.908,<answer>1:1</answer>,1:1,0,False,True
9e52daf6-ca58-43e8-e732-fbac3459d295,bix-54_q6,What is the R-squared value for the spline model fit to the colony area data?,,empty,0.8062,<answer> R-squared value not provided </answer>,R-squared value not provided,0,False,True
9e52daf6-ca58-43e8-e732-fbac3459d295,bix-54_q7,What is the maximum colony area (in mm²) predicted across all statistical models?,,empty,"184,372",<answer> The maximum colony area predicted is 563.85 mm² </answer>,The maximum colony area predicted is 563.85 mm²,0,False,True
